rfhg_18794.1

Basic information about the TSS

---

TSS ID: rfhg_18794.1 Species: human Chr: chr1		Start: 205719301 End: 205719358 Strand: -
Source datasets	PRJNA401781
Protocol	RAMPAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000464938.1:-368 GeneID: 64710 HGNC/MGI_ID: HGNC:29923 UniProt_ID: Nearer transcript ids and distances:

Gene_name: nuclear casein kinase and cyclin dependent kinase substrate 1 Gene_symbol: NUCKS1 Gene_synonyms: NUCKS Gene_source: HGNC:29923

TATA-Box annotation

---

Distance to TSS:	30853
Nearest PromoterID:	NM_022731
Entrez ID:	64710
Nearest Unigene:	Hs.213061
Nearest Refseq:	NM_022731
Nearest Ensembl:	ENSG00000069275
Gene Name:	nuclear casein kinase and cyclin dependent kinase substrate 1
Gene Alias:	JC7|NUCKS
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.431034
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NUCKS1 p2@NUCKS1 p3@NUCKS1 p4@NUCKS1 p5@NUCKS1 p6@NUCKS1 p7@NUCKS1
Sample		p1@NUCKS1	p2@NUCKS1	p3@NUCKS1	p4@NUCKS1	p5@NUCKS1	p6@NUCKS1	p7@NUCKS1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.22	21.04	1.95	0.19	0.39	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.94	26.91	2.23	0.00	0.00	1.42	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	35.69	25.85	2.51	0.58	0.00	1.54	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	17.88	13.31	1.66	0.00	0.21	0.42	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	26.10	17.77	1.80	0.00	0.00	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	23.45	16.47	1.94	0.19	0.19	0.78	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	34.43	31.16	2.83	0.00	0.22	1.09	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	23.74	13.32	1.94	0.00	0.00	0.73	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	21.80	11.97	1.50	0.00	0.00	0.64	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	23.76	6.38	1.16	0.58	0.00	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.72	11.72	1.62	0.00	0.00	1.62	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	17.48	6.50	1.22	0.00	0.00	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.70	8.87	2.26	0.16	0.00	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.88	6.47	1.35	0.15	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.64	4.61	1.54	0.00	0.00	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.54	7.54	1.51	0.25	0.25	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.55	5.24	1.97	0.00	0.44	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.39	8.86	3.37	0.42	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	5.33	0.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.43	5.72	2.41	0.15	0.30	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.42	6.28	1.87	0.00	0.27	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.15	6.04	2.93	0.00	0.00	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.31	6.33	1.94	0.13	0.00	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.01	4.37	0.97	0.00	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11.09	7.22	2.32	0.52	0.26	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.65	9.18	1.58	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.69	8.79	0.55	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.32	12.02	2.59	0.00	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.18	5.65	2.10	0.32	0.00	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	8.51	5.79	0.72	0.18	0.00	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.44	4.61	1.88	0.00	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.03	7.42	1.37	0.00	0.39	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.81	6.33	3.59	0.42	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.90	8.74	1.65	0.16	0.16	0.33	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.28	7.48	1.12	0.19	0.00	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.50	4.98	1.53	0.19	0.00	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.26	5.72	1.23	0.00	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.46	4.84	1.21	0.20	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.37	5.67	2.43	0.00	0.54	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.28	7.20	0.72	0.00	0.24	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.76	6.59	1.88	0.00	0.00	0.24	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	6.59	4.68	1.17	0.00	0.44	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.33	6.96	1.05	0.00	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.57	6.29	1.05	0.17	0.17	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.84	6.22	1.00	0.60	0.80	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.28	10.93	2.09	0.47	0.23	0.23	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	5.04	2.16	1.20	0.00	0.00	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.05	4.77	1.19	0.00	0.60	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	5.51	4.07	1.68	0.24	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	5.46	3.84	1.21	0.61	0.00	0.00	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	4.71	4.71	2.25	0.00	0.20	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.78	8.45	2.89	0.22	0.44	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	293.84	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5.68	5.32	2.13	0.00	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.29	4.31	1.66	0.33	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	31.04	68.79	1.68	0.00	1.68	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.27	19.75	2.30	0.00	0.46	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.08	6.16	2.92	0.32	0.00	0.00	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.64	5.78	4.18	0.32	0.00	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	17.29	8.49	3.46	0.00	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.87	4.94	1.41	0.00	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.29	2.24	2.80	0.00	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.13	23.09	3.98	0.80	3.18	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.80	11.55	1.70	0.00	0.00	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.55	2.27	0.97	0.32	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	9.23	7.10	3.55	0.35	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	129.31	242.46	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	134.26	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	4.39	3.41	0.00	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	4.46	3.97	6.45	0.00	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.38	3.75	0.47	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.22	7.62	2.32	0.66	0.00	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.45	4.33	2.78	0.00	0.31	0.31	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.56	5.20	2.14	0.31	0.00	0.31	1.83
Adipocyte - breast, donor1	11376-118A8	8.55	6.49	0.32	0.00	0.16	0.32	0.79
Adipocyte - breast, donor2	11327-117E4	13.32	10.59	1.76	0.00	0.16	0.80	1.12
Adipocyte - omental, donor1	11473-119C6	14.89	4.07	0.76	0.00	0.13	0.76	0.64
Adipocyte - omental, donor2	11474-119C7	9.72	8.97	3.74	0.00	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	21.10	4.69	0.33	0.00	0.00	1.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	24.88	7.02	2.55	0.00	0.00	0.64	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	1.10	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	13.10	4.52	0.45	0.00	0.00	0.45	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	14.25	8.17	0.00	0.00	0.00	0.87	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	69.43	2.35	0.39	0.00	0.00	1.56	2.15
Adipocyte differentiation, day04, donor2	13022-139D7	33.97	2.32	0.26	0.00	0.00	0.77	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	38.47	4.18	0.56	0.28	0.00	3.07	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	32.92	3.53	0.59	0.59	0.00	1.18	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	90.57	4.26	0.16	0.00	0.00	2.33	2.49
Adipocyte differentiation, day08, donor2	13023-139D8	43.57	5.49	0.65	0.00	0.00	0.32	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	32.52	6.40	0.53	0.00	0.00	3.73	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	42.29	4.45	0.00	0.00	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	66.13	5.41	0.42	0.00	0.00	3.33	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	35.67	4.02	0.00	0.25	0.00	1.00	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	35.67	2.29	0.00	0.00	0.00	0.98	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	50.24	3.04	0.61	0.00	0.00	1.52	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	13.48	3.98	0.00	0.00	0.00	0.66	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	5.02	1.08	0.00	0.00	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	2.40	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	23.39	3.24	0.18	0.00	0.00	1.08	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	10.04	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	22.80	3.90	0.21	0.00	0.00	0.62	1.03
Anulus Pulposus Cell, donor1	11248-116E6	63.16	7.09	0.57	0.00	0.11	2.86	1.83
Anulus Pulposus Cell, donor2	11463-119B5	45.06	7.59	0.24	0.00	0.00	1.22	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	34.15	9.44	0.45	0.00	0.00	2.70	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.37	9.55	0.43	0.00	0.00	1.74	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	17.12	0.00	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.92	9.86	0.30	0.00	0.00	0.60	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	37.94	10.12	2.53	0.00	0.00	0.00	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	19.80	4.62	1.32	0.00	0.00	2.64	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	24.37	9.10	0.32	0.00	0.00	0.97	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	44.66	6.80	0.49	0.00	0.00	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	8.91	0.59	0.00	0.59	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	33.14	8.66	0.00	0.00	0.00	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.77	8.71	0.00	0.00	0.00	2.18	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	5.02	0.00	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	19.93	2.14	0.00	0.00	0.00	1.98	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	6.82	0.00	1.36	0.00	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.79	1.96	0.15	0.00	0.00	0.60	1.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	39.11	8.57	0.00	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	36.28	7.18	0.00	0.00	0.00	1.13	2.46
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	28.87	10.69	0.00	0.00	0.00	1.34	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	16.58	7.80	0.00	0.98	0.00	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	36.65	4.98	0.17	0.00	0.00	1.49	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	7.20	0.00	0.00	0.00	3.60	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	22.64	9.95	0.34	0.00	0.00	1.03	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	12.58	4.19	0.00	0.00	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	36.89	7.28	0.49	0.00	0.00	1.94	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	30.74	10.62	0.00	0.00	0.00	2.28	3.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	6.06	0.00	1.21	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	31.92	6.27	0.00	0.00	0.00	0.57	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.49	6.20	0.00	0.00	0.43	1.50	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.42	8.52	0.26	0.00	0.00	1.81	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	21.58	3.75	0.00	0.00	0.00	1.41	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	15.11	9.65	0.32	0.00	0.00	1.29	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.12	1.43	0.00	0.00	0.00	2.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.13	6.43	1.17	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	22.88	6.02	0.00	0.00	0.00	1.51	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	5.94	0.00	0.00	0.00	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	31.02	7.12	0.00	0.00	0.00	1.02	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.39	15.79	0.25	0.00	0.25	0.51	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.15	3.18	0.64	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	25.46	3.88	0.43	0.00	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	33.87	4.45	0.00	0.00	0.00	1.48	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.37	5.80	0.29	0.00	0.00	0.58	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	25.51	6.61	0.00	0.00	0.00	2.83	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.80	4.07	0.34	0.00	0.00	0.51	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	11.58	4.63	0.00	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	8.45	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	19.94	5.15	0.21	0.00	0.21	0.86	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	3.61	0.00	0.00	0.00	0.00	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	27.70	8.02	0.00	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	33.79	10.34	0.00	0.00	0.00	2.07	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	30.60	0.00	0.00	0.00	0.00	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	15.25	1.78	0.51	0.00	0.25	1.27	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.86	7.64	0.41	0.00	0.00	2.48	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	23.87	10.40	0.61	0.31	0.00	2.75	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	37.76	6.69	0.00	0.48	0.00	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.83	5.77	1.11	0.00	0.00	1.55	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	3.05	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	29.91	3.88	1.11	0.00	0.00	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	30.45	7.41	0.26	0.00	0.00	1.59	2.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.17	6.18	1.09	0.00	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	27.88	3.68	0.61	0.00	0.00	0.61	0.98
Astrocyte - cerebellum, donor2	11580-120F5	25.85	2.74	0.00	0.17	0.00	0.17	0.86
Astrocyte - cerebellum, donor3	11661-122F5	14.68	2.10	0.00	0.00	0.00	0.21	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	120.26	13.25	2.09	0.00	0.00	2.09	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	113.89	26.21	1.94	0.00	0.32	3.07	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	93.23	14.17	2.39	0.00	0.15	0.75	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	94.04	16.97	0.34	0.00	0.00	2.75	2.52
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	97.34	16.16	0.25	0.13	0.00	1.88	1.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	85.01	13.20	0.11	0.00	0.00	2.39	2.50
Basophils, donor1	12241-129G9	6.54	0.78	0.00	0.00	0.00	0.00	0.78
Basophils, donor2	12242-129H1	22.37	1.08	0.00	0.00	0.00	1.08	1.44
Basophils, donor3	12243-129H2	23.81	0.59	0.15	0.00	0.00	0.44	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	11.86	1.29	0.00	0.00	0.00	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	1.37	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.97	1.26	0.00	0.00	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	17.05	1.25	0.00	0.00	0.00	0.83	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	16.12	2.53	0.00	0.00	0.00	1.15	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	53.98	15.84	0.36	0.00	0.36	3.96	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	62.97	15.97	0.72	0.00	0.21	2.47	2.27
Burkitt's lymphoma cell line:RAJI	10476-106I8	40.06	20.50	0.70	0.23	0.47	0.93	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	33.26	2.24	0.00	0.00	0.00	0.00	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	22.54	0.00	0.00	0.00	0.00	1.13	0.56
CD14+ Monocytes, donor2	11305-117B9	8.35	2.97	0.00	0.00	0.00	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	16.03	1.10	0.00	0.00	0.00	1.10	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	40.19	2.55	0.28	0.00	0.00	1.13	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	28.81	2.65	0.00	0.00	0.00	1.14	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	57.53	1.64	0.33	0.00	0.00	1.64	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	4.48	1.88	0.00	0.00	0.00	0.14	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	5.13	1.51	0.00	0.00	0.00	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	3.55	0.95	0.00	0.00	0.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.52	0.84	0.00	0.00	0.00	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.31	0.83	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.48	0.25	0.25	0.00	0.00	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.11	0.59	0.00	0.00	0.00	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.74	0.89	0.36	0.18	0.00	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	2.83	0.22	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	4.92	0.70	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	4.22	1.06	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	2.22	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.42	2.38	0.15	0.00	0.15	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.39	1.60	0.20	0.00	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.71	0.21	0.00	0.00	0.00	0.62	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.75	2.52	0.23	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.71	0.68	0.00	0.00	0.00	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.75	1.31	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.03	0.54	0.00	0.00	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	6.63	1.92	0.17	0.17	0.00	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.05	0.84	0.00	0.00	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.02	3.67	0.00	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.11	0.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.53	0.70	0.00	0.00	0.00	0.00	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.46	4.46	0.00	0.00	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.90	0.22	0.00	0.00	0.00	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.37	1.64	0.00	0.00	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.32	1.16	0.00	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.32	0.23	0.23	0.00	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	6.76	2.62	0.22	0.22	0.22	0.65	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	14.32	2.08	0.00	0.00	0.00	1.39	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	9.10	1.30	0.00	0.22	0.22	1.08	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	10.12	2.18	0.00	0.00	0.00	0.93	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	10.30	1.05	0.17	0.00	0.00	0.52	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	9.14	0.89	0.00	0.00	0.00	0.89	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	12.76	2.30	0.26	0.00	0.00	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	14.71	1.76	0.00	0.00	0.00	0.66	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	12.21	1.05	0.63	0.00	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	26.44	5.42	0.00	0.00	0.00	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	34.17	2.07	0.00	0.00	0.00	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	37.31	3.73	0.53	0.00	0.00	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	49.85	2.68	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	29.48	0.70	0.00	0.00	0.00	0.70	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.81	0.78	0.00	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	35.59	6.59	0.00	0.00	0.00	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	46.03	7.40	0.82	0.00	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	33.37	6.53	0.00	0.73	0.00	0.00	2.90
CD19+ B Cells, donor3	11705-123B4	33.32	6.06	0.50	0.00	0.00	1.01	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	83.64	14.55	1.21	0.00	0.00	3.23	5.25
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	41.55	9.99	0.00	0.00	0.40	2.40	1.60
CD34+ Progenitors, donor1	11545-120B6	11.04	1.00	0.00	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	29.21	2.81	0.00	0.00	0.00	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	43.59	5.26	0.75	0.38	0.00	1.13	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	45.55	5.19	0.00	0.00	0.00	0.68	0.90
CD4+ T Cells, donor1	11225-116C1	59.99	7.14	0.36	0.00	0.00	1.79	0.71
CD4+ T Cells, donor2	11306-117C1	61.24	15.31	1.22	0.00	0.00	2.45	0.00
CD4+ T Cells, donor3	11382-118B5	36.29	11.89	0.00	0.00	0.30	0.61	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	38.29	2.04	0.51	0.00	0.00	1.28	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	29.87	2.47	0.22	0.00	0.22	0.67	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	34.78	2.87	0.00	0.00	0.00	1.72	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	38.40	6.16	0.00	0.00	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	43.54	3.51	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	6.59	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	30.93	2.89	0.43	0.00	0.29	1.30	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	22.03	7.96	0.17	0.00	0.00	0.51	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.66	7.90	0.32	0.16	0.00	0.97	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	20.17	3.59	0.90	0.00	0.00	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	20.96	4.19	0.00	0.00	0.00	1.05	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	21.56	2.20	0.00	0.00	0.44	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	25.72	3.37	0.84	0.00	0.00	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	25.56	10.60	0.21	0.21	0.00	0.42	2.29
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	18.71	5.01	0.33	0.00	0.00	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	31.54	6.25	0.54	0.00	0.00	1.36	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	38.59	2.14	0.00	0.00	0.54	0.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	23.31	3.59	0.00	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	46.54	6.30	0.37	0.00	0.00	2.04	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	26.86	3.03	0.00	0.00	0.00	0.43	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	32.36	2.52	0.84	0.00	0.00	1.68	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	34.38	3.03	0.51	0.00	0.51	1.01	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	37.26	4.33	0.00	0.00	0.00	0.87	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	31.81	2.61	0.44	0.00	0.00	0.00	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	45.53	4.45	0.49	0.49	0.00	2.47	3.96
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	44.31	5.54	0.00	0.00	0.00	0.92	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	41.87	1.40	0.00	0.00	0.00	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	58.99	3.60	0.00	0.00	0.00	1.11	3.32
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	78.28	6.13	0.49	0.00	0.00	3.19	4.91
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	4.62	1.54	0.00	0.00	3.08	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	55.87	3.94	0.72	0.00	0.00	1.79	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	65.09	2.77	0.00	0.00	0.00	1.38	4.15
CD8+ T Cells, donor1	11226-116C2	37.00	6.88	0.33	0.00	0.00	0.65	0.98
CD8+ T Cells, donor2	11307-117C2	45.43	13.52	1.50	0.00	0.38	1.13	1.50
CD8+ T Cells, donor3	11383-118B6	74.23	13.63	0.50	0.00	0.00	1.26	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	36.93	23.63	1.61	0.00	0.00	2.75	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	36.43	28.04	1.44	0.00	0.24	2.88	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	45.14	33.10	1.37	0.27	0.27	5.75	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	61.24	23.42	0.60	0.00	0.60	2.10	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	22.80	29.04	1.44	0.00	0.00	1.20	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	28.65	12.05	2.05	0.00	0.45	2.27	2.05
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	44.11	20.86	1.30	0.00	0.00	5.87	2.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	37.64	15.00	2.90	0.00	0.26	3.68	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.54	13.60	0.94	0.00	0.47	3.05	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.32	41.36	3.62	0.30	0.00	2.11	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	53.16	25.56	2.61	0.29	0.58	4.94	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	34.64	13.32	1.33	0.27	0.00	2.13	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	25.83	2.63	1.75	0.44	0.00	0.88	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	28.69	5.47	0.46	0.00	0.00	2.28	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	4.48	0.75	0.00	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	34.94	8.28	1.44	0.00	0.00	5.76	3.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	36.54	15.82	0.86	0.00	0.00	4.32	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	35.12	9.66	1.18	0.00	0.24	3.30	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	49.44	16.16	0.32	0.00	0.00	2.85	2.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	42.75	11.99	1.23	0.00	0.00	3.69	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	40.71	8.66	0.32	0.00	0.00	3.85	2.89
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	39.78	13.39	1.15	0.00	0.00	3.82	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	43.35	15.76	1.58	0.00	0.00	1.97	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	26.47	15.13	3.78	0.00	0.76	5.29	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	61.02	12.04	3.21	0.00	0.00	4.01	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	61.55	18.19	0.70	0.00	0.70	6.29	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	56.10	15.03	2.00	0.00	0.00	3.01	4.01
Cardiac Myocyte, donor1	11525-119I4	63.97	7.31	10.97	0.00	0.00	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	61.76	9.88	0.00	0.00	0.00	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	71.45	3.16	0.00	0.00	0.00	2.42	0.95
Chondrocyte - de diff, donor1	11261-116G1	13.87	10.40	2.43	0.00	0.00	1.04	0.69
Chondrocyte - de diff, donor2	11338-117F6	26.65	3.55	0.00	0.00	0.00	0.71	0.71
Chondrocyte - de diff, donor3	11410-118E6	18.32	10.81	0.80	0.00	0.00	0.68	0.34
Chondrocyte - re diff, donor2	11339-117F7	57.30	0.90	0.90	0.00	0.00	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	26.69	4.04	0.40	0.00	0.00	0.00	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	116.25	10.79	0.57	0.11	0.00	2.75	2.30
Ciliary Epithelial Cells, donor2	11323-117D9	66.48	15.18	1.50	0.00	0.00	2.14	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	90.71	12.21	0.71	0.18	0.09	1.06	1.59
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	61.16	4.77	0.00	0.00	0.09	3.76	2.29
Corneal Epithelial Cells, donor1	11526-119I5	6.81	0.66	0.00	0.00	0.00	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	10.24	2.28	1.14	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	25.31	3.32	0.51	0.00	0.00	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	28.89	3.14	0.33	0.00	0.00	1.32	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	27.44	4.10	0.00	0.00	0.00	0.63	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	6.90	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	39.74	3.35	0.54	0.00	0.00	1.62	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	47.15	3.76	0.00	0.00	0.00	0.34	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	46.35	3.92	0.00	0.00	0.00	1.31	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	41.14	2.90	0.00	0.00	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	48.53	1.00	0.00	0.00	0.00	1.33	2.33
Endothelial Cells - Aortic, donor1	11263-116G3	19.95	1.76	0.00	0.00	0.00	2.93	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	28.56	3.68	0.00	0.28	0.00	1.13	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	30.28	0.79	0.00	0.00	0.00	2.75	0.39
Endothelial Cells - Artery, donor1	11264-116G4	18.62	2.91	0.00	0.00	0.00	1.16	0.58
Endothelial Cells - Artery, donor2	11341-117F9	26.12	12.00	0.24	0.00	0.00	0.94	0.24
Endothelial Cells - Artery, donor3	11413-118E9	47.68	2.28	0.18	0.00	0.00	0.70	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	28.15	3.55	0.00	0.00	0.00	1.33	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	28.60	3.04	0.30	0.00	0.00	1.22	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	24.53	1.13	1.13	0.00	0.00	0.85	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	9.21	4.16	0.00	0.00	0.00	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	17.18	0.00	0.00	0.00	0.00	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	10.92	8.79	0.00	0.00	0.00	0.85	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	37.61	4.80	0.80	0.00	0.00	2.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	4.19	4.19	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	110.83	9.32	1.37	0.00	0.25	3.85	2.11
Endothelial Cells - Umbilical vein, donor2	11324-117E1	129.92	12.17	0.22	0.22	0.43	1.52	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	145.21	8.92	0.37	0.12	0.12	3.66	2.44
Endothelial Cells - Vein, donor1	11267-116G7	27.30	0.00	0.00	0.00	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	17.46	1.40	0.00	0.00	0.00	0.00	1.40
Endothelial Cells - Vein, donor3	11416-118F3	60.60	3.93	0.47	0.00	0.00	0.94	1.26
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	1.65	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	17.10	1.47	0.00	0.00	0.00	0.49	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	23.81	7.80	1.23	0.00	0.41	1.64	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	17.52	3.61	1.09	0.11	0.00	1.64	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	39.00	8.67	2.71	0.22	0.11	1.30	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	61.97	9.94	1.33	0.24	0.12	2.91	1.33
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	17.88	2.18	0.27	0.00	0.00	1.50	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	29.53	8.23	1.05	0.00	0.11	1.69	1.27
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	40.05	7.90	0.26	0.00	0.00	1.58	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	76.07	15.28	0.33	0.00	0.66	1.66	2.66
Fibroblast - Cardiac, donor1	11268-116G8	49.45	5.90	0.91	0.00	0.00	1.36	1.81
Fibroblast - Cardiac, donor2	11345-117G4	17.43	0.76	0.00	0.00	0.00	1.52	1.52
Fibroblast - Cardiac, donor3	11417-118F4	12.46	5.20	0.47	0.16	0.00	0.47	0.32
Fibroblast - Cardiac, donor4	11452-119A3	71.84	2.42	0.00	0.00	0.00	2.73	1.52
Fibroblast - Cardiac, donor5	11456-119A7	70.56	6.09	0.51	0.00	0.13	1.90	1.40
Fibroblast - Cardiac, donor6	11460-119B2	74.28	8.79	0.76	0.00	0.00	2.88	2.12
Fibroblast - Choroid Plexus, donor1	11492-119E7	26.66	2.01	0.00	0.00	0.00	0.94	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	48.75	9.49	0.43	0.00	1.29	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	99.61	35.16	5.86	1.46	0.00	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	31.83	1.38	0.00	0.00	0.00	1.38	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	45.11	4.92	0.51	0.00	0.00	1.36	1.53
Fibroblast - Dermal, donor1	11269-116G9	26.77	3.52	0.47	0.00	0.47	0.94	0.47
Fibroblast - Dermal, donor2	11346-117G5	23.58	0.47	0.00	0.00	0.47	1.42	0.94
Fibroblast - Dermal, donor3	11418-118F5	31.43	8.58	0.36	0.12	0.00	0.36	0.60
Fibroblast - Dermal, donor4	11450-119A1	92.81	11.30	0.23	0.11	0.00	2.03	2.37
Fibroblast - Dermal, donor5	11454-119A5	94.73	8.72	1.05	0.00	0.52	1.22	2.09
Fibroblast - Dermal, donor6	11458-119A9	105.41	10.72	0.32	0.00	0.32	1.62	2.27
Fibroblast - Gingival, donor1	11237-116D4	56.01	4.37	0.00	0.00	0.00	1.67	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	61.05	3.41	0.52	0.26	0.26	2.62	2.10
Fibroblast - Gingival, donor2	11318-117D4	58.12	21.88	0.92	0.00	0.26	1.71	1.58
Fibroblast - Gingival, donor3	11394-118C8	65.26	3.87	0.10	0.00	0.00	2.22	1.45
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	48.83	4.16	0.00	0.00	0.00	3.12	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	33.83	10.57	0.35	0.00	0.18	1.06	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	89.17	9.67	0.47	0.00	0.16	2.65	2.65
Fibroblast - Gingival, donor6 (control)	11922-125H5	63.15	8.25	0.54	0.27	0.14	3.11	2.43
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	59.28	0.35	0.00	0.00	0.00	4.59	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	72.54	6.14	0.00	0.00	0.15	2.78	2.34
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	68.45	8.86	0.95	0.14	0.41	3.27	1.64
Fibroblast - Gingival, donor8 (control)	11926-125H9	120.33	7.35	0.44	0.00	0.22	3.40	3.07
Fibroblast - Gingival, donor9 (control)	11927-125I1	52.53	3.82	0.15	0.00	0.15	2.93	1.91
Fibroblast - Lung, donor1	11270-116H1	24.47	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	7.46	0.00	1.49	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	19.63	8.65	1.06	0.21	0.00	0.63	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	1.67	0.00	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	0.00	0.00	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	4.76	0.28	0.00	0.00	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	29.64	0.81	0.00	0.00	0.00	1.62	0.41
Fibroblast - Mammary, donor2	11620-122A9	15.98	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	119.29	11.44	0.58	0.00	0.00	2.72	2.33
Fibroblast - Periodontal Ligament, donor2	11319-117D5	122.86	15.02	0.46	0.00	0.00	2.28	2.28
Fibroblast - Periodontal Ligament, donor3	11395-118C9	70.99	1.53	0.31	0.00	0.00	2.75	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	54.19	3.05	0.38	0.00	0.00	1.14	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	43.74	6.48	0.81	0.00	0.00	2.16	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	42.68	3.83	0.35	0.00	0.12	1.39	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	74.61	7.96	0.55	0.00	0.11	2.43	1.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	22.15	1.02	0.41	0.00	0.00	0.81	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	34.75	2.00	0.00	0.00	0.00	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	67.21	7.51	0.40	0.00	0.00	1.58	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	54.97	11.71	0.99	0.00	0.20	0.99	2.58
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	36.59	8.88	0.89	0.00	0.00	1.07	1.78
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	39.22	13.01	0.99	0.20	0.20	1.58	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.38	7.82	0.60	0.00	0.00	0.00	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	73.51	8.53	0.43	0.00	0.11	2.59	2.37
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	36.70	3.29	0.00	0.00	0.00	2.28	2.53
Fibroblast - skin normal, donor1	11553-120C5	27.89	5.91	0.33	0.16	0.16	2.13	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	33.08	6.02	0.40	0.00	0.00	1.20	1.00
Fibroblast - skin normal, donor2	11561-120D4	59.77	8.04	0.50	0.00	0.10	2.81	1.81
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	47.75	7.25	0.00	0.30	0.30	0.60	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	41.17	5.80	0.58	0.08	0.00	1.66	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	60.17	9.92	0.34	0.00	0.00	1.37	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	27.59	7.55	0.33	0.00	0.00	1.64	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	68.81	10.12	0.53	0.00	0.00	2.24	2.02
Fibroblast - skin walker warburg, donor1	11554-120C6	55.83	11.64	0.17	0.00	0.00	0.51	1.52
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	51.28	13.17	2.04	0.00	0.16	2.67	1.73
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	930.71	332.40	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	33.12	4.36	0.87	0.00	0.00	2.61	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	28.95	2.77	0.00	0.00	0.00	2.95	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	23.94	2.08	0.26	0.00	0.00	1.56	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	29.13	1.53	0.26	0.00	0.00	0.77	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	104.88	6.89	0.77	0.00	0.00	3.83	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	107.20	19.14	0.64	0.00	0.00	3.19	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	213.09	71.60	2.00	1.43	0.29	5.99	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	155.53	43.02	4.69	0.55	0.55	3.31	4.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	86.76	19.64	1.60	0.23	0.46	2.28	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	126.21	42.20	3.17	0.00	0.99	3.17	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	177.10	41.76	2.91	1.06	0.53	4.23	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	69.47	13.05	1.30	0.33	0.00	3.59	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	103.04	89.77	2.65	0.00	1.33	4.86	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	157.01	23.32	1.13	0.00	0.00	1.13	1.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	145.06	22.54	1.23	0.25	0.49	2.09	1.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	118.20	21.22	1.61	0.00	0.00	1.88	3.22
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	80.04	13.63	0.87	0.00	0.00	0.99	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	106.03	23.95	0.83	0.14	0.00	1.11	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	97.99	20.53	0.61	0.00	0.41	1.63	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	57.04	12.55	1.14	0.23	0.46	1.14	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	92.43	17.31	0.50	0.00	0.12	1.37	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	89.18	9.62	0.87	0.00	1.09	1.09	1.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.37	11.23	0.89	0.30	0.00	0.89	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	109.36	29.73	1.27	0.00	0.00	0.95	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	82.67	12.29	0.22	0.00	0.67	2.46	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	93.56	16.33	0.40	0.00	0.00	0.81	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	120.11	29.52	1.02	0.17	0.17	1.36	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	48.24	9.58	0.62	0.09	0.18	1.77	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.09	5.51	1.25	0.00	0.10	0.42	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.86	4.78	0.17	0.00	0.00	0.51	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	115.63	12.95	0.44	0.11	0.44	1.55	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.51	9.07	0.92	0.00	0.08	0.67	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.12	6.53	0.41	0.20	0.00	0.82	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	55.70	13.20	0.83	0.21	0.00	1.24	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	104.80	17.29	1.04	0.12	0.23	1.61	1.50
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	85.55	9.51	0.83	0.00	0.00	2.17	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	51.14	11.90	1.10	0.00	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	83.88	14.51	0.49	0.25	0.25	1.11	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	59.16	17.67	1.95	0.00	0.16	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	48.11	17.32	0.64	0.00	0.00	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	95.99	12.51	0.47	0.00	0.00	1.80	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	63.43	9.33	0.32	0.00	0.00	0.95	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	42.88	16.72	0.30	0.00	0.30	0.30	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	77.99	12.75	0.94	0.21	0.10	1.05	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	60.16	6.81	0.22	0.00	0.00	1.54	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	47.13	12.62	0.84	0.00	0.28	2.52	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	50.83	4.81	0.37	0.00	0.19	1.20	1.57
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.02	12.30	0.27	0.00	0.00	1.60	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	58.45	11.17	0.46	0.00	0.31	1.07	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	64.25	11.53	0.00	0.13	0.26	2.07	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	58.82	4.34	0.27	0.00	0.00	1.36	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	64.34	11.43	0.74	0.00	0.37	1.29	2.21
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	54.83	12.06	0.66	0.22	0.22	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	71.41	6.94	0.00	0.00	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	46.43	8.84	0.40	0.00	0.00	1.19	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	41.36	9.28	0.20	0.00	0.40	0.61	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	28.97	1.27	0.76	0.00	0.51	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	132.18	18.51	0.60	0.00	0.20	2.39	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	154.38	22.80	1.54	0.00	0.00	2.93	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	170.01	25.78	0.82	0.41	0.20	2.86	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	66.03	10.64	0.63	0.31	0.00	1.25	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	85.05	10.45	1.70	0.00	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	111.15	29.06	6.46	1.84	0.00	2.77	3.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	94.04	69.29	4.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	93.22	49.12	3.09	0.39	0.39	1.55	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	93.06	25.67	6.42	0.00	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	74.77	83.46	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	70.30	44.92	4.23	0.33	0.00	2.28	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	83.18	49.00	4.94	0.41	0.82	0.82	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	109.96	176.61	10.00	3.33	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	56.49	33.56	1.68	0.00	0.28	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	58.18	47.72	3.92	0.65	0.33	0.65	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	57.04	175.32	9.23	0.00	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	52.48	35.31	2.86	0.64	0.32	2.23	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	67.59	44.16	2.38	1.02	0.34	2.04	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	52.20	66.82	2.09	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	62.42	37.80	3.44	0.00	2.86	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	35.81	37.59	2.66	0.00	0.00	0.30	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	54.21	127.06	5.08	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	73.73	48.05	1.24	0.41	0.00	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	61.67	31.30	3.45	0.00	0.00	0.92	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	94.83	5.27	0.00	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	47.67	30.37	3.46	0.00	0.38	0.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	44.98	29.34	1.96	0.00	0.00	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	54.84	13.38	2.01	0.00	0.00	0.67	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	41.61	35.83	1.93	0.77	0.00	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	63.68	31.15	3.08	0.34	0.00	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	86.97	2.48	2.48	7.45	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	46.71	33.03	3.77	0.47	0.00	2.36	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	59.75	30.78	7.24	1.21	0.00	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	39.17	13.73	0.00	0.51	0.51	1.53	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	67.00	28.32	2.39	0.00	0.40	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	61.18	38.98	5.43	0.00	0.49	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	27.15	44.86	5.90	0.00	1.18	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	42.59	35.01	2.92	0.00	0.00	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	38.62	23.26	4.83	0.00	0.44	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	42.38	5.09	0.85	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	31.64	42.98	7.76	0.00	0.00	2.98	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	20.87	34.45	4.85	0.00	0.00	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	20.54	1.14	0.00	0.00	0.00	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.97	19.96	0.42	0.00	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	22.49	3.37	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	35.20	10.15	0.63	0.00	0.00	1.59	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	33.84	5.85	0.00	0.00	0.00	1.67	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	145.98	30.64	1.86	0.35	0.46	4.18	4.06
Hep-2 cells mock treated, biol_rep2	11899-125E9	156.99	31.57	1.35	0.17	0.51	4.56	5.40
Hep-2 cells mock treated, biol_rep3	11900-125F1	135.59	27.30	1.59	0.00	0.23	4.32	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	158.50	33.34	1.31	0.11	0.11	3.50	3.94
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	136.90	22.57	0.43	0.21	0.00	5.80	3.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	132.61	25.40	1.29	0.00	0.00	3.23	3.66
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	126.28	39.10	2.86	0.00	0.00	2.37	3.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	125.40	26.42	1.37	0.00	0.34	3.60	2.92
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	125.27	29.15	2.24	0.00	0.00	3.84	2.88
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	26.30	3.36	0.00	0.00	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.12	0.43	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	23.79	2.64	0.00	2.64	0.00	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	19.05	2.47	0.00	0.00	0.00	1.06	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	2.18	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	97.73	15.56	1.05	0.35	0.00	3.67	1.57
Hepatocyte, donor1	11523-119I2	18.16	43.58	2.42	0.00	0.00	1.21	2.42
Hepatocyte, donor2	11603-120I1	15.08	22.62	0.00	0.00	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	53.38	13.50	0.00	0.00	0.61	0.61	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.23	11.75	0.65	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	72.01	8.39	0.35	0.17	0.00	2.10	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	61.74	4.53	0.00	0.00	0.00	1.78	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	0.00	0.00	0.00	0.00	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	0.00	0.00	0.00	0.00	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	5.00	0.00	0.00	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	18.53	3.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	24.56	2.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	0.00	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	29.72	1.94	0.00	0.00	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	15.48	0.81	0.00	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	8.82	0.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	28.93	1.61	0.00	0.00	0.00	0.80	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	1.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.58	3.78	0.00	0.00	0.00	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.95	1.81	0.91	0.00	0.00	1.81	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	24.75	1.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	0.00	0.00	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.30	1.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	20.71	1.43	0.00	0.00	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	3.32	0.00	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	36.73	4.32	0.31	0.00	0.00	1.23	2.16
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	28.10	0.00	0.00	0.00	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	17.38	0.00	0.00	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	0.00	0.00	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	19.18	0.87	0.00	0.00	0.00	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	0.00	0.00	0.00	0.00	0.00	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	16.00	2.13	0.00	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	1.39	0.00	0.00	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	17.49	2.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	1.06	0.00	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.63	2.28	0.24	0.00	0.08	0.49	0.57
Keratinocyte - epidermal, donor2	11349-117G8	7.03	1.17	0.00	0.00	0.00	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	40.13	14.96	0.47	0.00	0.00	0.28	0.76
Keratinocyte - oral, donor1	11251-116E9	86.73	8.74	0.45	0.00	0.00	3.75	3.41
Keratocytes, donor1	11527-119I6	34.04	3.44	0.00	0.00	0.00	1.38	0.34
Keratocytes, donor2	11607-120I5	32.81	3.52	0.00	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	46.63	5.73	0.20	0.59	0.20	0.99	1.78
Krukenberg tumor cell line:HSKTC	10687-109F3	123.08	8.79	2.20	0.00	0.00	0.00	8.79
Lens Epithelial Cells, donor1	11529-119I8	63.65	12.94	0.00	0.00	0.00	2.16	1.08
Lens Epithelial Cells, donor2	11609-120I7	82.35	5.19	0.58	0.12	0.00	1.61	1.04
Lens Epithelial Cells, donor3	11690-122I7	70.03	3.13	0.30	0.00	0.10	1.92	2.22
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	33.44	4.39	0.24	0.00	0.00	1.07	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	19.81	14.51	0.56	0.00	0.00	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.34	29.75	0.63	0.16	0.00	0.79	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.67	5.91	0.00	1.08	0.00	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.81	7.25	0.63	0.00	0.32	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.40	8.19	0.54	0.11	0.00	0.11	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.85	13.13	0.41	0.00	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.81	5.56	0.00	0.00	0.00	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.68	17.73	0.00	0.00	0.00	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	23.34	3.56	0.00	0.79	0.00	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.23	15.32	0.78	0.00	0.00	1.16	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.26	5.18	0.19	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.21	11.15	0.35	0.00	0.35	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	18.84	11.69	0.48	0.00	0.24	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.22	13.87	0.14	0.00	0.14	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	24.64	10.47	0.00	0.00	0.31	1.23	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.48	6.55	0.62	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.25	11.35	0.73	0.00	0.00	0.37	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.71	11.52	1.32	0.00	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.79	6.44	0.88	0.00	0.00	0.88	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.21	4.73	0.00	0.00	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	34.43	10.67	0.48	0.00	0.00	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	16.97	10.23	0.27	0.00	0.00	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	14.08	8.48	0.15	0.00	0.15	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	19.70	5.18	0.00	0.00	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.70	19.47	0.21	0.00	0.21	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	14.89	10.83	0.00	0.00	0.15	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	4.13	0.00	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.25	6.96	0.19	0.00	0.00	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	10.18	10.07	0.21	0.00	0.00	0.53	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.51	9.69	0.00	0.48	0.00	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.55	8.27	0.33	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.67	14.99	0.25	0.12	0.00	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	24.06	8.14	0.00	0.00	0.00	0.74	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.57	8.40	0.49	0.00	0.25	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.35	5.64	0.27	0.00	0.00	0.41	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.44	7.08	0.32	0.00	0.00	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.04	11.87	0.30	0.00	0.30	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	13.58	17.78	0.70	0.00	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	16.71	6.40	0.36	0.00	0.00	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	6.79	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.29	5.14	0.00	0.00	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	27.57	5.73	0.72	0.00	0.00	1.07	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.74	2.29	0.00	0.00	0.00	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	5.18	0.00	0.00	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	24.38	3.96	0.00	0.00	0.00	1.11	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.68	5.38	0.26	0.00	0.00	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.85	6.86	0.30	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	45.32	2.27	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	60.60	8.44	1.53	0.00	0.00	1.53	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	54.18	10.39	0.00	0.00	0.00	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	30.89	12.27	1.69	0.00	0.42	1.69	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	32.35	12.66	0.70	0.00	0.00	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	5.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	23.70	15.97	3.09	0.00	0.52	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	27.36	4.76	0.00	0.00	0.00	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.62	4.98	0.45	0.23	0.00	0.68	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	63.69	38.10	5.53	0.29	0.58	2.04	2.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	122.90	34.66	4.95	0.00	0.00	2.70	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	40.24	6.77	0.00	0.00	0.27	1.90	1.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	36.97	14.89	1.54	0.00	0.51	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	89.27	19.76	4.94	0.00	0.00	1.76	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	63.30	20.66	2.00	0.67	0.00	1.33	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	32.60	15.28	5.60	0.51	0.51	2.55	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	85.11	26.95	4.00	0.27	0.53	1.07	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	85.78	41.76	2.46	0.19	1.32	3.21	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	27.61	15.95	3.07	0.61	0.00	1.84	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	70.13	22.83	0.82	0.82	0.82	3.26	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	119.32	39.36	3.75	0.42	0.62	1.87	2.71
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	65.02	37.84	6.17	0.56	1.40	3.36	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	60.79	13.39	0.00	0.00	0.00	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	104.22	54.58	4.64	0.00	1.16	2.03	2.61
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	63.97	22.72	3.89	1.20	0.90	1.79	2.99
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	83.54	19.36	2.77	0.00	0.00	3.32	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	69.28	18.38	1.77	0.00	0.00	0.71	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	47.94	21.76	2.95	0.00	0.37	1.84	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	43.75	11.51	2.30	0.00	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	59.10	16.50	2.69	0.00	0.00	2.30	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	33.97	22.08	3.40	0.00	0.57	2.26	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	61.54	13.13	0.82	0.00	0.82	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	44.28	14.01	2.71	0.00	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	45.24	13.64	2.15	0.00	0.00	0.72	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	35.85	13.44	1.49	0.00	0.00	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	54.25	27.50	1.86	0.37	0.00	0.74	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	54.70	16.80	3.02	0.00	1.29	2.58	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	79.64	11.99	2.57	0.00	0.86	2.57	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	69.97	26.32	1.67	0.00	1.00	1.67	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	31.98	15.08	1.81	0.00	0.60	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	46.93	8.53	0.00	0.00	0.00	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	48.81	16.50	2.41	0.00	0.69	2.75	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	35.43	14.49	2.68	0.00	1.07	2.68	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	43.77	10.77	1.35	1.35	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	68.90	21.85	3.33	0.74	0.74	1.85	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	38.38	0.00	0.00	0.00	0.00	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	48.66	8.46	1.06	0.00	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	56.02	20.01	2.40	0.00	0.00	1.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.26	4.36	0.00	0.00	0.00	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	39.09	6.90	0.77	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.64	13.81	3.95	0.00	0.49	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	4.70	7.53	2.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	38.21	11.56	1.01	0.00	0.50	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.70	13.52	1.35	0.00	0.00	1.80	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	15.49	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	34.29	12.91	1.34	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	50.44	16.42	0.39	0.00	0.00	1.56	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.33	6.60	1.32	0.00	0.00	0.00	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	53.97	16.09	1.04	0.52	0.00	3.11	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.45	23.19	1.31	0.00	0.44	1.31	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	49.76	13.42	2.24	0.00	0.56	1.68	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	60.06	8.83	1.77	0.00	0.44	2.65	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	75.99	18.90	0.39	0.39	1.16	1.54	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	44.05	13.17	4.05	0.51	0.51	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	67.29	14.90	0.96	0.48	0.00	2.40	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	50.09	20.67	1.99	0.40	0.40	0.80	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	39.50	13.98	2.43	0.00	1.22	1.22	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	44.27	11.07	1.38	0.00	0.00	1.38	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	57.76	15.58	1.52	0.00	0.38	2.66	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	28.92	17.04	0.52	0.00	0.52	1.55	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	35.67	11.49	0.60	0.60	0.00	1.21	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	58.31	25.67	0.95	0.00	0.00	1.58	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	26.12	6.40	1.07	0.00	0.00	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	25.86	6.32	1.15	0.57	0.57	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	42.17	12.86	1.54	0.00	0.00	3.60	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	31.12	12.03	2.12	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	29.51	8.51	0.57	0.00	0.00	0.57	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	47.43	14.56	0.42	0.42	0.42	1.66	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	28.97	9.40	2.35	0.00	0.78	0.78	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.48	7.52	0.84	0.00	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	36.24	11.15	1.39	0.00	0.00	1.86	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	23.42	10.70	2.01	0.00	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	55.07	15.50	1.07	0.00	0.00	1.60	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	48.49	17.38	2.02	0.00	0.40	1.21	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	4.59	0.00	0.00	0.00	0.92	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	33.79	15.11	0.89	0.00	1.78	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	37.61	4.56	0.57	0.00	0.00	1.71	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.94	6.14	1.53	0.00	0.00	3.07	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	51.43	18.60	1.09	0.55	0.00	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	36.53	10.25	1.34	0.00	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	33.53	3.90	0.26	0.00	0.00	1.56	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	46.42	4.64	1.33	0.00	0.66	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	18.71	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	28.26	2.51	0.00	0.00	0.00	0.91	2.28
Macrophage - monocyte derived, donor2	11313-117C8	23.86	1.84	0.00	0.00	0.00	2.02	1.28
Macrophage - monocyte derived, donor3	11389-118C3	44.31	3.93	0.13	0.13	0.00	2.49	1.97
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.15	0.53	0.53	0.00	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	30.11	5.70	0.00	0.00	0.00	1.74	1.90
Mallassez-derived cells, donor3	11930-125I4	35.72	5.14	0.14	0.00	0.00	1.95	1.53
Mammary Epithelial Cell, donor1	11273-116H4	57.29	17.84	1.10	0.00	0.00	1.89	3.49
Mammary Epithelial Cell, donor2	11350-117G9	21.14	18.53	0.87	0.00	0.00	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	29.68	2.00	0.00	0.00	0.00	1.25	0.50
Mast cell - stimulated, donor1	11487-119E2	46.10	9.49	0.00	0.00	0.00	2.03	1.36
Mast cell, donor1	11563-120D6	45.20	5.84	0.32	0.11	0.00	0.43	1.95
Mast cell, donor2	11565-120D8	123.92	2.97	0.30	0.00	0.00	4.46	10.10
Mast cell, donor3	11566-120D9	140.03	2.48	0.00	0.00	0.00	4.50	11.71
Mast cell, donor4	11567-120E1	110.98	3.72	0.35	0.00	0.00	4.96	9.22
Mast cell, expanded and stimulated, donor5	11940-126A5	54.67	5.10	0.11	0.00	0.11	2.55	2.55
Mast cell, expanded and stimulated, donor8	11942-126A7	16.93	2.33	0.58	0.00	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	44.86	7.11	0.11	0.00	0.00	0.80	1.26
Mast cell, expanded, donor8	11941-126A6	46.36	2.68	0.50	0.17	0.00	2.01	2.01
Melanocyte - dark, donor1	11502-119F8	66.76	5.47	0.30	0.00	0.00	0.99	0.80
Melanocyte - dark, donor2	11582-120F7	61.60	8.65	0.00	0.00	0.69	1.38	1.04
Melanocyte - dark, donor3	11663-122F7	72.15	7.46	0.51	0.00	0.00	1.67	1.88
Melanocyte - light, donor1	11274-116H5	12.93	3.53	0.00	0.00	0.00	0.47	0.00
Melanocyte - light, donor2	11351-117H1	10.92	0.00	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	11.27	1.73	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	80.49	7.60	0.42	0.10	0.10	2.19	2.19
Melanocyte, donor2 (MC+2)	12739-135I3	40.88	8.07	0.27	0.27	0.00	1.34	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	55.71	5.09	0.54	0.00	0.27	2.14	0.54
Meningeal Cells, donor1	11493-119E8	48.63	3.35	0.37	0.00	0.00	1.74	0.99
Meningeal Cells, donor2	11573-120E7	52.38	3.08	0.44	0.00	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	83.78	9.62	1.14	0.00	0.00	1.47	1.87
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	96.67	5.13	0.57	0.00	0.00	2.57	2.85
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	7.04	1.91	0.20	0.10	0.00	0.60	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00	0.00	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	2.62	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	54.54	17.22	1.44	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	26.89	8.05	1.06	0.00	0.00	1.48	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.60	6.03	1.01	0.50	0.50	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	19.12	3.96	0.00	0.00	0.00	1.10	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.03	12.42	0.00	0.00	0.00	0.73	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	19.85	2.86	0.00	0.00	0.00	0.41	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	34.90	5.26	0.42	0.00	0.00	1.66	1.80
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.81	1.12	0.37	0.00	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	46.97	7.37	0.53	0.26	0.13	1.84	1.05
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.20	0.59	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	27.54	2.56	0.00	0.00	0.00	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	74.43	6.73	0.35	0.00	0.00	3.90	2.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	55.35	4.69	0.31	0.00	0.00	2.19	1.88
Mesenchymal stem cells - umbilical, donor0	11214-116A8	70.39	4.35	0.73	0.00	0.00	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	10.61	3.98	0.80	0.00	0.00	0.00	0.80
Mesothelial Cells, donor2	12156-128G5	17.52	1.00	0.00	0.00	0.00	1.00	1.00
Mesothelial Cells, donor3	11402-118D7	13.80	14.45	0.29	0.07	0.07	0.29	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	29.71	1.35	0.00	0.00	0.00	4.05	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	35.71	6.16	0.99	0.25	0.00	0.74	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.37	3.83	0.00	0.00	0.29	1.18	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.01	3.41	0.31	0.00	0.00	1.24	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.62	7.88	0.00	0.00	0.21	0.41	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	24.28	4.75	0.75	0.00	0.25	0.50	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.15	1.86	0.93	0.00	1.40	3.72	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	23.78	4.67	0.00	0.00	0.00	0.81	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.92	6.34	0.00	0.00	0.00	0.00	2.38
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	19.47	0.88	0.88	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	13.68	6.84	0.00	0.00	0.00	1.52	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	1.32	0.00	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.34	4.67	0.00	0.00	0.00	1.70	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	14.73	2.76	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	4.47	0.30	0.00	0.00	0.60	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	1.68	0.00	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	4.01	0.25	0.00	0.00	0.50	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	21.15	6.42	0.24	0.00	0.00	0.95	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.37	0.00	0.00	0.55	0.00	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.89	4.14	0.00	0.00	0.23	0.69	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.31	2.73	0.00	0.00	0.00	1.26	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.56	1.63	0.20	0.00	0.00	0.61	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.02	2.57	0.43	0.00	0.00	1.29	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	19.56	0.89	0.00	0.00	0.00	1.56	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.86	1.75	0.00	0.00	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.70	0.00	0.00	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	9.51	0.82	0.00	0.00	0.00	1.36	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.53	2.06	0.59	0.00	0.00	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	0.00	0.00	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.13	1.44	0.00	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.81	1.60	0.40	0.00	0.00	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.02	3.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.95	1.75	0.44	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.92	1.49	0.00	0.00	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.97	3.42	0.34	0.00	0.00	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	0.44	0.00	0.00	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.36	1.07	0.00	0.00	0.00	1.07	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.50	2.81	0.56	0.00	0.00	0.56	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	0.42	0.00	0.00	0.00	0.83	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.16	0.58	0.00	0.00	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.27	1.81	0.90	0.00	0.00	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.60	2.50	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.01	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.26	2.28	0.00	0.00	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.51	1.11	0.00	0.00	0.00	0.97	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.33	1.55	0.00	0.00	0.00	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	14.16	0.86	0.00	0.00	0.00	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	0.00	0.00	0.00	0.00	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.54	1.33	0.27	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.77	3.29	0.60	0.00	0.00	0.00	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.87	0.99	0.00	0.00	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.83	1.59	0.00	0.00	0.32	0.64	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	13.71	1.33	0.00	0.00	0.00	0.88	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.06	1.99	0.00	0.00	0.00	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	13.52	2.21	0.25	0.00	0.00	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	0.65	0.00	0.00	0.00	0.00	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.58	1.18	0.00	0.00	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.70	2.31	0.00	0.00	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	13.19	1.24	0.00	0.00	0.00	0.41	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	16.38	0.89	0.00	0.00	0.00	0.89	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	3.77	0.00	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.70	7.89	0.66	0.00	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	7.36	0.00	0.00	0.00	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	18.98	2.37	0.20	0.00	0.00	0.99	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	20.49	0.93	0.00	0.00	0.00	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.53	11.27	0.38	0.00	0.38	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.05	1.60	0.27	0.00	0.00	0.80	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.53	1.47	0.00	0.00	0.00	0.90	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	8.84	0.00	0.00	0.00	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.92	5.13	0.73	0.00	0.00	1.10	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	21.78	10.89	4.67	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.03	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	20.20	6.06	1.01	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	17.71	4.64	0.00	0.00	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	2.72	0.00	0.00	0.00	2.72	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.72	1.27	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	29.15	3.24	0.00	0.00	0.00	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	1.51	0.00	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	19.60	10.99	1.08	0.00	0.00	0.86	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	33.97	5.75	0.00	0.00	0.00	2.61	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.69	2.00	1.33	0.00	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	19.62	1.67	0.83	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	59.89	5.51	0.38	0.00	0.76	0.57	3.42
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	86.18	11.17	1.60	0.00	0.00	4.79	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	0.68	2.72	0.00	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	192.95	23.89	0.00	0.00	0.00	5.51	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	23.02	1.67	1.67	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.96	1.86	1.39	0.00	0.23	1.39	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	19.46	1.89	0.54	0.27	0.27	0.54	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	19.55	4.20	0.84	0.00	0.00	1.05	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	400.85	155.89	0.00	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.36	2.98	0.00	0.00	0.50	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	38.16	7.04	1.89	0.00	0.00	2.98	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	18.13	0.68	1.81	0.23	0.23	0.68	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.78	1.14	1.14	0.00	0.16	0.82	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	32.26	6.74	0.55	0.00	0.18	1.46	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	18.57	2.12	1.06	0.00	0.00	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	21.61	0.00	0.60	0.60	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	53.82	8.86	1.97	0.33	0.98	2.95	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	21.79	1.79	1.14	0.00	0.16	0.65	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.40	4.23	0.18	0.00	0.18	0.88	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.17	2.11	2.81	0.00	0.00	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	29.88	1.84	1.38	0.00	0.00	1.38	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	28.28	0.96	1.29	0.00	0.00	0.32	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	71.39	9.66	4.48	0.00	1.72	3.79	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	316.06	35.40	0.00	2.53	0.00	2.53	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.83	3.34	0.45	0.00	0.00	1.34	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	18.21	3.81	2.54	0.42	0.00	1.69	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	31.57	3.80	1.90	0.00	0.00	0.71	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	23.18	3.00	0.00	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	379.17	99.31	0.00	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.66	1.33	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.64	3.16	0.00	0.00	0.00	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.92	2.78	0.79	0.00	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	16.72	5.57	0.00	0.00	0.00	1.86	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	32.16	1.89	1.14	0.38	0.00	0.38	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.34	3.26	0.98	0.33	0.00	1.63	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.84	0.87	0.87	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.02	5.43	0.45	0.00	0.00	0.90	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	18.52	0.88	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.96	1.33	1.99	0.00	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.41	2.48	1.49	0.50	0.00	0.50	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.87	2.68	1.91	0.00	0.00	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	25.41	3.33	0.60	0.00	0.30	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	28.29	4.20	0.00	0.00	0.00	1.11	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.88	2.03	0.68	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	173.72	76.64	0.00	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.29	1.83	2.44	0.00	0.00	3.05	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.70	2.20	1.57	0.00	0.00	0.63	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.65	2.12	0.91	0.00	0.30	1.21	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	2.37	0.79	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	57.82	7.94	4.53	0.00	2.27	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	182.08	35.41	5.06	0.00	5.06	5.06	5.06
Myoblast, donor1	11241-116D8	42.73	5.71	1.12	0.00	0.00	2.24	1.99
Myoblast, donor2	11322-117D8	60.03	10.93	1.53	0.19	0.19	4.22	1.92
Myoblast, donor3	11398-118D3	50.45	4.71	0.34	0.00	0.00	2.52	2.02
NK T cell leukemia cell line:KHYG-1	10777-110G3	52.97	9.19	0.73	0.00	0.15	0.88	1.17
Natural Killer Cells, donor1	11230-116C6	43.05	3.69	0.00	0.00	0.00	0.62	2.46
Natural Killer Cells, donor2	11311-117C6	51.57	15.68	0.00	0.00	0.00	1.21	1.21
Natural Killer Cells, donor3	11387-118C1	54.30	9.75	0.18	0.00	0.00	1.29	1.84
Neural stem cells, donor1	11275-116H6	19.96	9.44	0.00	0.00	0.00	0.73	0.36
Neural stem cells, donor2	11352-117H2	15.41	3.85	0.00	0.00	0.00	1.93	1.93
Neurons, donor1	11494-119E9	86.48	13.65	0.00	0.00	0.00	2.28	2.28
Neurons, donor2	11574-120E8	51.30	4.62	0.22	0.00	0.00	0.88	1.32
Neurons, donor3	11655-122E8	69.06	16.44	2.47	0.00	0.00	0.82	1.64
Neutrophils, donor1	11233-116C9	6.50	0.93	0.00	0.00	0.00	3.71	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	6.72	0.00	0.61	0.00	0.00	1.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	55.69	6.65	0.59	0.00	0.00	2.37	1.54
Nucleus Pulposus Cell, donor2	11409-118E5	19.86	8.79	0.33	0.00	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	40.31	5.82	0.20	0.00	0.00	1.40	0.80
Olfactory epithelial cells, donor1	11933-125I7	40.06	7.85	0.41	0.14	0.28	1.51	1.10
Olfactory epithelial cells, donor2	11934-125I8	58.33	28.95	1.74	0.00	0.00	2.03	1.30
Olfactory epithelial cells, donor3	11935-125I9	46.20	7.83	0.11	0.00	0.11	3.06	1.82
Olfactory epithelial cells, donor4	11936-126A1	46.36	11.79	0.78	0.29	0.39	1.85	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	71.01	3.61	0.60	0.00	0.00	1.81	1.20
Osteoblast - differentiated, donor1	11276-116H7	26.59	1.06	0.00	0.00	0.00	1.91	1.91
Osteoblast - differentiated, donor2	11353-117H3	13.72	0.00	0.00	0.00	0.00	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	16.76	3.10	0.00	0.00	0.00	1.24	0.62
Osteoblast, donor1	11277-116H8	28.92	1.37	0.20	0.00	0.00	1.17	1.17
Osteoblast, donor2	11354-117H4	28.80	18.26	0.70	0.00	0.70	1.40	4.21
Osteoblast, donor3	11426-118G4	74.11	4.09	0.36	0.00	0.18	1.60	1.42
Pancreatic stromal cells, donor1	11249-116E7	42.79	8.26	0.76	0.00	0.08	2.27	1.60
Pericytes, donor1	11491-119E6	7.79	0.56	0.00	0.00	0.00	0.33	0.00
Pericytes, donor2	11571-120E5	7.47	1.36	0.00	0.00	0.00	0.45	0.45
Pericytes, donor3	11652-122E5	23.80	3.66	0.41	0.00	0.20	0.20	0.81
Perineurial Cells, donor1	11499-119F5	42.16	9.27	0.57	0.11	0.11	0.79	1.02
Perineurial Cells, donor2	11579-120F4	78.03	3.86	0.09	0.09	0.00	1.66	1.75
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.77	2.55	0.32	0.00	0.00	2.55	2.87
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	40.16	6.12	0.49	0.00	0.00	1.22	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	53.19	2.20	0.13	0.00	0.00	1.94	1.29
Placental Epithelial Cells, donor1	11278-116H9	13.15	1.67	0.24	0.00	0.00	0.48	0.96
Placental Epithelial Cells, donor2	11355-117H5	7.76	5.54	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	24.34	4.32	0.20	0.20	0.20	0.39	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.18	0.95	2.22	0.00	0.00	1.58	0.32
Preadipocyte - breast, donor1	11467-119B9	8.44	2.25	0.75	0.00	0.00	0.56	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.23	2.87	0.26	0.00	0.00	0.78	1.17
Preadipocyte - breast, donor2	11328-117E5	16.89	6.75	0.90	0.00	0.00	1.13	0.23
Preadipocyte - omental, donor1	11468-119C1	14.81	3.30	0.53	0.00	0.00	0.96	0.85
Preadipocyte - omental, donor2	11329-117E6	13.97	2.18	0.44	0.00	0.44	1.75	0.00
Preadipocyte - omental, donor3	11403-118D8	30.80	11.89	1.72	0.14	0.14	1.15	1.43
Preadipocyte - perirenal, donor1	11469-119C2	13.78	2.95	0.00	0.00	0.00	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	14.13	0.31	0.00	0.00	0.00	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	31.34	14.70	2.30	0.18	0.00	0.71	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	25.54	5.62	0.17	0.17	0.00	1.19	1.02
Preadipocyte - visceral, donor1	11280-116I2	32.97	9.78	0.65	0.00	0.00	1.96	2.24
Preadipocyte - visceral, donor2	11357-117H7	23.47	9.20	0.00	0.00	0.00	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	24.76	7.73	0.63	0.00	0.10	1.15	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	59.74	10.11	0.60	0.15	0.15	1.81	0.91
Prostate Epithelial Cells, donor2	11331-117E8	13.95	4.33	0.41	0.14	0.00	2.03	1.08
Prostate Epithelial Cells, donor3	11404-118D9	43.29	16.23	0.67	0.06	0.12	5.76	2.88
Prostate Stromal Cells, donor1	11254-116F3	59.00	6.49	0.68	0.00	0.11	3.30	2.73
Prostate Stromal Cells, donor2	11332-117E9	45.72	35.32	0.90	0.00	0.00	3.23	1.43
Prostate Stromal Cells, donor3	11405-118E1	20.13	8.55	0.52	0.10	0.10	0.83	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.12	1.09	0.36	0.00	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	38.61	7.28	0.42	0.07	0.00	1.46	0.97
Renal Epithelial Cells, donor1	11517-119H5	12.17	1.01	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	25.61	4.98	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	42.56	10.37	0.32	0.00	0.21	2.22	1.38
Renal Glomerular Endothelial Cells, donor1	11514-119H2	13.62	1.36	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.01	5.53	0.54	0.00	0.13	0.67	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	102.12	28.20	0.44	1.78	1.55	2.66	2.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	1.33	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	13.21	3.74	0.22	0.00	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	20.69	5.64	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	10.54	0.83	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.82	3.49	0.27	0.00	0.00	0.81	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	16.87	3.80	0.00	0.00	0.00	1.27	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	28.16	4.44	0.39	0.00	0.00	0.58	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	81.16	9.07	0.78	0.00	0.00	3.37	1.81
Retinal Pigment Epithelial Cells, donor1	11528-119I7	16.77	1.99	0.28	0.00	0.00	0.57	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	1.03	0.00	0.00	0.00	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	16.56	3.76	0.25	0.00	0.25	1.51	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	74.30	7.48	0.94	0.13	0.00	4.54	3.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	49.14	5.36	0.00	0.00	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	53.94	44.03	2.75	0.55	0.00	0.55	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	102.67	20.30	0.58	0.00	0.00	2.90	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	97.78	7.28	0.65	0.13	0.26	2.34	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	108.54	22.05	0.00	0.10	0.30	3.08	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	52.87	11.04	1.12	0.11	0.00	1.56	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	144.26	41.18	0.87	0.12	0.37	2.36	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	114.91	21.09	0.82	0.12	0.47	3.15	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	70.73	27.97	0.92	0.23	0.23	2.77	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	90.09	12.32	0.41	0.14	0.00	1.37	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	89.25	22.84	0.76	0.15	0.30	2.27	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	60.92	5.20	0.18	0.00	0.00	3.05	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	68.29	16.50	1.58	0.29	1.15	2.01	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	85.10	18.67	0.64	0.21	0.11	1.93	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	55.10	13.28	0.44	0.22	0.22	0.22	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	66.91	7.84	0.57	0.00	0.19	1.91	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	109.19	10.99	0.56	0.09	0.28	2.98	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	32.13	18.60	0.56	0.00	0.00	0.38	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	85.99	9.69	0.13	0.13	0.13	1.73	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	56.36	19.37	0.88	0.00	0.39	0.97	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	55.95	17.95	1.53	0.19	0.38	1.34	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	61.62	10.36	0.64	0.32	0.32	1.39	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	43.73	37.56	2.24	0.84	0.84	0.84	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	65.62	20.34	0.51	0.00	0.00	1.37	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	50.51	9.66	0.55	0.00	0.73	0.91	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	65.61	21.58	0.49	0.00	0.37	1.96	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	60.58	14.51	0.54	0.13	0.13	1.61	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	52.13	18.63	0.94	0.00	0.24	0.94	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	89.09	22.82	0.79	0.40	0.00	2.58	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	43.50	18.24	0.47	0.00	0.23	1.64	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	94.14	12.65	0.62	0.21	0.00	2.28	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	63.93	37.83	0.22	0.22	0.22	2.21	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	72.90	12.53	0.63	0.00	0.21	0.84	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	97.04	15.61	0.94	0.13	0.27	1.88	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	71.69	8.69	0.17	0.17	0.00	1.36	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	46.66	20.24	0.96	0.19	0.58	2.31	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	65.51	13.58	1.03	0.17	0.34	3.27	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	92.73	11.39	1.10	0.27	0.27	2.06	2.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	50.07	20.85	0.66	0.00	0.16	1.31	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	55.56	10.06	0.85	0.17	0.17	2.05	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	42.32	25.15	0.74	0.00	0.30	0.89	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	40.78	9.86	0.00	0.00	0.00	1.07	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	62.91	8.02	0.28	0.14	0.14	1.11	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	46.19	11.67	0.24	0.00	0.00	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	73.97	8.06	0.20	0.20	0.00	1.81	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	63.19	11.49	0.85	0.09	0.19	1.70	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	39.13	26.20	1.05	0.00	0.35	1.75	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	81.90	10.28	1.51	0.00	0.00	1.51	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	49.44	11.99	0.49	0.24	0.00	0.86	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	92.86	8.88	1.02	0.00	0.00	2.04	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	93.09	9.73	1.22	0.00	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	56.06	8.14	0.30	0.60	0.30	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	44.56	10.40	0.45	0.23	0.23	0.45	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	80.58	14.98	1.50	0.00	0.30	1.50	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	34.95	8.74	0.47	0.00	0.00	0.71	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	73.85	2.77	0.21	0.21	0.43	1.28	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	99.76	5.41	2.40	0.60	0.00	1.20	1.80
Schwann Cells, donor1	11498-119F4	23.13	4.89	0.00	0.00	0.00	0.19	1.13
Schwann Cells, donor2	11578-120F3	54.44	30.62	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	78.43	25.85	1.53	0.22	0.00	1.97	1.75
Sebocyte, donor1	11220-116B5	12.60	0.55	0.00	0.00	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	12.41	4.14	0.46	0.00	0.46	0.92	0.00
Sebocyte, donor3	11378-118B1	11.54	1.65	0.00	0.00	0.00	0.41	0.21
Sertoli Cells, donor1	11255-116F4	36.45	8.28	3.31	0.00	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	25.42	11.30	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	18.30	5.63	0.35	0.18	0.00	0.70	0.62
Skeletal Muscle Cells, donor2	11358-117H8	21.69	1.45	0.00	0.00	0.00	0.72	1.45
Skeletal Muscle Cells, donor3	11430-118G8	41.80	3.34	0.00	0.00	0.00	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	80.12	10.68	0.79	0.16	0.00	2.51	3.30
Skeletal Muscle Cells, donor5	11455-119A6	74.92	12.34	1.49	0.00	0.00	2.38	1.64
Skeletal Muscle Cells, donor6	11459-119B1	92.80	9.23	0.46	0.15	0.46	2.15	2.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	89.59	9.07	0.76	0.00	0.25	2.90	2.27
Skeletal Muscle Satellite Cells, donor2	11321-117D7	69.35	10.84	0.57	0.00	0.00	2.71	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	112.60	9.62	0.79	0.20	0.60	2.68	1.39
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.77	12.47	0.76	0.08	0.17	0.84	2.02
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	30.40	2.17	0.00	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	21.47	2.34	0.14	0.00	0.00	1.24	0.28
Skin - palm, donor1	10286-104F7	10.74	2.69	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.34	4.32	1.30	0.00	0.00	1.87	2.16
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	12.27	0.00	1.64	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	24.54	2.60	0.91	0.13	0.00	1.30	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	37.12	7.23	0.70	0.00	0.00	4.17	3.34
Small Airway Epithelial Cells, donor2	11334-117F2	54.43	8.72	0.00	0.00	0.00	4.08	2.67
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	30.03	3.38	0.85	0.21	0.00	1.48	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	81.10	6.15	0.30	0.00	0.15	6.45	5.62
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.05	9.87	0.62	0.31	0.31	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.68	2.89	0.44	0.00	0.00	2.22	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	31.15	2.35	0.00	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	34.70	1.99	0.00	0.00	0.00	1.33	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	14.57	0.79	0.00	0.00	0.00	1.97	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	21.63	0.77	0.00	0.00	0.00	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	20.02	14.01	1.00	0.00	0.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.69	1.06	0.00	0.00	0.00	2.00	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	20.39	9.09	0.89	0.00	0.00	1.55	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	34.70	3.46	0.13	0.00	0.13	2.18	1.54
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	34.84	3.58	0.65	0.00	0.00	0.98	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	43.71	2.66	0.00	0.00	0.00	0.89	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.66	2.99	0.71	0.00	0.14	0.71	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.46	0.65	0.00	0.00	0.00	0.49	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	42.32	8.83	0.00	1.22	0.61	1.83	2.44
Smooth Muscle Cells - Carotid, donor1	11285-116I7	26.27	1.52	0.00	0.00	0.00	1.52	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	122.41	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	15.74	0.00	0.00	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	34.66	5.60	0.29	0.00	0.00	1.03	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	37.88	9.04	0.00	0.22	0.43	1.29	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	55.73	7.35	0.63	0.00	0.10	1.26	1.36
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	22.27	0.62	0.31	0.00	0.00	1.39	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	0.00	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	19.43	4.78	0.60	0.00	0.00	1.49	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	20.14	0.00	0.00	0.00	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.43	7.70	0.47	0.08	0.08	2.04	1.18
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	26.47	5.13	0.40	0.10	0.00	2.52	1.51
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	15.70	7.05	0.23	0.00	0.00	2.05	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	4.83	0.00	0.00	0.00	1.21	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	136.17	7.95	1.59	0.00	0.26	3.18	3.44
Smooth Muscle Cells - Prostate, donor1	11257-116F6	59.26	7.32	0.27	0.00	0.13	2.00	2.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	21.41	13.40	1.13	0.00	0.25	0.88	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.68	1.78	0.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	51.87	3.32	0.45	0.00	0.00	2.41	1.81
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	28.51	4.50	0.00	0.00	0.00	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	153.77	9.05	0.00	0.00	0.00	0.00	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	25.58	0.93	0.47	0.00	0.00	4.19	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	1.51	0.00	0.00	0.00	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.49	1.88	0.31	0.00	0.00	1.25	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.31	1.47	0.00	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	141.37	3.50	0.42	0.00	0.00	3.00	3.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	41.11	2.34	0.00	0.00	0.00	1.40	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	21.88	1.30	0.00	0.00	0.00	1.15	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	33.14	2.29	0.25	0.00	0.00	2.29	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	27.64	2.07	0.00	0.00	0.00	0.75	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	85.10	7.41	0.70	0.00	0.14	2.10	3.07
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	36.87	4.19	0.25	0.00	0.00	1.26	1.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.29	0.00	0.00	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	20.06	0.24	0.00	0.00	0.00	1.96	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.87	7.29	0.88	0.00	0.00	1.33	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.80	5.27	0.29	0.00	0.00	1.17	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	23.52	4.08	0.00	0.00	0.19	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.28	5.55	1.06	0.00	0.26	1.06	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	16.37	8.55	1.49	0.00	0.37	2.98	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.73	8.62	1.80	0.00	0.72	0.36	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	12.21	1.99	0.00	0.00	0.00	1.42	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	52.78	19.30	0.79	0.00	0.39	1.97	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	21.33	11.43	2.54	0.51	0.25	1.52	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	24.36	5.99	0.80	0.40	0.00	0.40	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	15.88	8.78	0.42	0.00	0.00	2.09	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	18.33	4.58	0.92	0.00	0.00	0.92	0.92
Synoviocyte, donor1	11291-117A4	8.42	6.23	0.50	0.00	0.00	0.50	0.17
Synoviocyte, donor2	11368-117I9	24.81	5.70	0.67	0.17	0.34	0.67	0.17
Synoviocyte, donor3	11440-118H9	22.79	9.61	0.22	0.00	0.45	1.34	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	21.08	2.50	0.00	0.00	0.00	0.71	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	3.96	0.00	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	24.31	1.39	0.00	0.23	0.00	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	37.28	1.94	0.22	0.00	0.00	1.65	1.36
Tracheal Epithelial Cells, donor2	11369-118A1	17.78	1.55	0.00	0.00	0.00	0.77	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	10.88	1.15	0.00	0.00	0.00	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	72.83	7.50	0.37	0.00	0.12	2.58	3.44
Urethra, donor2	10319-105A4	17.98	7.19	0.00	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	10.63	1.33	0.00	0.00	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	12.02	1.20	0.00	0.00	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	8.71	1.60	0.23	0.00	0.00	0.23	0.46
Urothelial cells, donor0	11216-116B1	53.72	6.46	1.11	0.00	0.22	1.78	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	31.14	3.56	0.00	0.00	0.00	3.56	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	24.30	5.72	0.00	0.00	0.00	1.43	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	31.49	6.85	1.37	0.00	0.00	1.37	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	28.92	2.41	0.34	0.00	0.00	2.07	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	27.31	2.91	0.00	0.00	0.00	1.74	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	18.74	1.04	0.00	0.00	0.00	2.08	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.03	5.51	0.00	0.00	0.00	0.00	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	23.74	3.65	0.00	0.00	0.00	1.83	1.83
Wilms' tumor cell line:G-401	10809-111A8	84.01	12.71	1.73	0.00	0.00	3.21	1.23
Wilms' tumor cell line:HFWT	10597-108E3	18.48	3.52	0.00	0.00	0.00	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	75.42	25.42	0.56	0.00	0.00	2.79	2.23
achilles tendon, donor2	10292-104G4	35.13	8.27	4.13	2.07	2.07	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	87.45	82.86	8.41	0.25	0.25	2.04	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	171.58	22.52	0.93	0.00	0.23	2.09	3.48
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	70.63	15.08	2.02	0.12	0.12	0.71	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	50.34	49.25	2.45	0.00	0.00	1.90	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	101.75	46.38	2.25	0.00	0.00	0.84	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	30.45	4.86	0.85	0.00	0.21	0.63	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.29	11.16	2.45	0.00	0.00	1.63	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	26.88	20.71	0.88	0.00	0.44	0.44	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	38.39	33.49	2.04	0.00	0.00	0.82	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	66.79	22.52	2.33	0.00	0.78	1.94	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	49.50	19.50	0.37	0.00	0.18	1.66	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	51.36	32.30	0.93	0.00	0.00	1.16	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	92.17	35.21	1.55	0.00	0.00	2.33	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	82.71	56.40	1.46	0.00	0.88	3.21	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	93.88	10.69	0.00	0.00	0.46	0.46	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.86	6.17	2.06	0.41	0.00	1.65	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	99.14	7.37	6.75	14.43	9.82	0.92	3.07
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	123.75	22.19	0.85	0.00	0.00	3.84	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	112.22	13.04	2.12	0.00	0.00	2.43	2.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	86.17	14.20	1.44	0.24	0.48	4.09	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	98.90	27.84	0.67	0.00	0.22	2.67	4.90
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	112.41	14.01	1.00	0.00	0.00	3.00	2.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	57.60	13.01	1.86	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	47.84	13.56	1.13	0.00	0.75	1.51	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	121.24	15.70	0.87	0.00	0.44	1.74	4.36
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	159.33	5.62	0.00	0.00	0.00	3.75	7.50
adenocarcinoma cell line:IM95m	10796-110I4	50.63	4.95	0.00	0.00	0.24	1.18	2.12
adipose tissue, adult, pool1	10010-101C1	61.12	4.19	0.47	0.00	0.16	2.95	3.88
adipose, donor1	10184-103D4	425.15	72.13	5.28	0.00	0.00	7.04	5.28
adipose, donor2	10185-103D5	36.50	10.54	2.84	0.00	0.00	2.03	1.22
adipose, donor3	10186-103D6	86.59	21.78	1.63	0.00	0.00	1.09	1.09
adipose, donor4	10187-103D7	228.82	60.67	0.87	0.00	0.87	2.60	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	134.30	6.15	0.32	0.16	0.00	5.37	2.21
adrenal gland, adult, pool1	10081-102A9	50.93	0.00	0.00	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	74.44	8.00	0.67	0.00	0.13	2.40	2.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	130.06	19.65	1.07	0.00	0.00	5.00	8.22
amniotic membrane cells, donor1	12235-129G3	48.69	7.65	0.46	0.00	0.00	2.09	1.39
amniotic membrane cells, donor2	12236-129G4	93.65	7.78	1.35	0.00	0.34	2.37	1.35
amniotic membrane cells, donor3	12237-129G5	69.82	9.72	0.00	0.29	0.00	5.01	2.95
amygdala - adult, donor10196	10167-103B5	124.51	13.04	0.00	0.00	1.19	4.74	8.30
amygdala, adult, donor10252	10151-102I7	172.56	20.48	1.62	1.42	2.03	7.50	5.88
amygdala, newborn, donor10223	10360-105E9	59.71	5.81	0.32	0.00	0.00	5.81	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	10.31	3.57	0.25	0.00	0.00	0.38	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	86.48	46.11	3.53	0.22	1.76	2.21	3.31
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.12	9.69	1.34	0.33	0.67	1.00	1.00
aorta, adult, pool1	10052-101G7	81.00	11.38	0.98	0.00	0.59	2.55	2.75
appendix, adult	10189-103D9	76.07	3.88	0.39	0.39	0.00	1.55	5.82
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	30.61	7.22	0.34	0.00	0.00	0.34	0.69
artery, adult	10190-103E1	54.35	12.23	1.36	0.00	0.00	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	29.55	6.08	0.43	0.14	0.00	0.58	0.29
b cell line:RPMI1788	10427-106D4	52.19	8.92	0.30	0.00	0.00	2.53	1.93
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.20	5.55	1.39	0.00	0.28	0.55	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	67.38	6.15	0.10	0.00	0.00	1.79	1.98
bile duct carcinoma cell line:TFK-1	10496-107C1	98.08	7.20	1.00	0.00	0.50	3.51	2.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	63.75	9.51	0.56	0.00	0.56	3.36	0.56
bladder, adult, pool1	10011-101C2	107.45	5.54	0.54	0.11	0.22	5.21	5.00
blood, adult, pool1	10053-101G8	31.00	6.64	0.00	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	44.53	2.57	0.86	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	18.90	21.59	0.00	0.67	0.67	0.67	0.67
brain, adult, donor1	10084-102B3	57.40	15.38	1.03	2.05	1.03	5.13	4.10
brain, adult, pool1	10012-101C3	151.56	14.37	1.45	0.00	0.56	8.02	8.46
brain, fetal, pool1	10085-102B4	61.44	5.34	0.00	0.00	0.00	0.00	5.34
breast carcinoma cell line:MCF7	10482-107A5	76.64	44.93	0.99	0.66	0.99	2.97	2.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	173.00	13.23	0.12	0.12	0.12	6.74	8.74
breast, adult, donor1	10080-102A8	44.83	1.89	0.63	0.00	0.00	1.89	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	111.16	18.93	1.27	0.00	0.25	3.05	4.32
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	104.21	15.46	0.31	0.31	0.31	2.47	3.09
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	46.73	9.90	0.92	0.23	0.46	2.99	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	149.13	33.41	2.18	0.24	1.69	3.87	4.12
carcinoid cell line:NCI-H1770	10703-109H1	101.09	13.63	1.88	0.94	0.47	3.76	2.82
carcinoid cell line:NCI-H727	10735-110B6	45.06	6.13	0.22	0.00	0.11	0.88	1.64
carcinoid cell line:SK-PN-DW	10719-109I8	51.02	7.92	1.90	0.00	0.00	0.95	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	129.89	43.92	1.60	0.27	0.27	7.99	3.73
caudate nucleus - adult, donor10196	10177-103C6	110.53	5.76	4.61	0.00	1.15	9.21	5.76
caudate nucleus, adult, donor10252	10164-103B2	159.96	20.58	1.51	0.67	2.01	10.21	10.54
caudate nucleus, adult, donor10258	10379-105H1	105.45	23.69	0.76	0.76	1.53	7.64	2.29
caudate nucleus, newborn, donor10223	10354-105E3	55.30	4.03	0.00	0.73	0.00	4.76	2.93
cerebellum - adult, donor10196	10173-103C2	171.88	20.39	0.00	2.91	0.00	5.83	5.83
cerebellum, adult, donor10252	10166-103B4	210.73	21.14	1.49	1.28	0.21	8.54	11.96
cerebellum, adult, pool1	10083-102B2	93.83	31.05	3.45	0.00	1.03	3.79	4.83
cerebellum, newborn, donor10223	10357-105E6	112.92	14.11	0.83	0.00	0.00	4.15	4.98
cerebral meninges, adult	10188-103D8	110.44	9.08	0.50	0.00	0.50	4.54	5.80
cerebrospinal fluid, donor2	10294-104G6	38.01	15.35	2.19	0.00	0.00	2.19	1.46
cervical cancer cell line:D98-AH2	10552-107I3	116.46	8.63	0.43	0.14	0.00	4.31	3.88
cervical cancer cell line:ME-180	10553-107I4	60.65	5.97	0.83	0.00	0.17	1.99	1.99
cervix, adult, pool1	10013-101C4	139.01	10.39	0.52	0.10	0.31	7.77	8.50
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	27.73	3.90	0.98	0.00	0.00	0.84	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	67.93	3.92	0.00	0.00	0.00	1.31	2.61
choriocarcinoma cell line:BeWo	10423-106C9	79.79	38.15	1.86	0.00	0.12	2.36	2.61
choriocarcinoma cell line:SCH	10785-110H2	88.10	20.21	0.62	0.00	0.12	1.97	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	120.01	4.51	0.24	0.00	0.00	1.66	1.19
chorionic membrane cells, donor1	12238-129G6	27.64	8.26	0.28	0.00	0.00	1.14	3.13
chorionic membrane cells, donor2	12239-129G7	50.61	5.47	0.50	0.00	0.20	1.29	0.89
chorionic membrane cells, donor3	12240-129G8	26.92	21.43	0.55	0.55	0.00	1.65	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	17.17	24.24	1.01	0.00	0.00	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	84.72	7.88	1.15	0.00	0.00	1.73	1.73
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	70.75	7.18	2.11	0.00	0.21	1.27	3.59
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	122.24	8.47	0.26	0.00	0.26	2.05	5.14
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	155.29	14.51	0.73	0.00	0.00	5.32	4.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	63.73	12.01	1.02	0.00	0.00	1.83	1.83
chronic myelogenous leukemia cell line:K562	10454-106G4	40.05	16.20	0.29	0.00	0.00	1.18	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	100.08	8.86	0.26	0.00	0.00	0.78	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	53.95	29.03	1.83	0.00	0.46	2.06	1.14
clear cell carcinoma cell line:TEN	10636-108I6	47.02	14.57	1.21	0.00	0.17	2.08	1.74
colon carcinoma cell line:CACO-2	10513-107D9	49.97	4.76	0.73	0.00	0.18	0.37	0.92
colon carcinoma cell line:COLO-320	10420-106C6	55.87	9.88	0.00	0.00	0.00	1.52	1.14
colon, adult, donor1	10082-102B1	48.79	3.57	1.19	0.00	0.00	2.38	3.57
colon, adult, pool1	10014-101C5	87.66	3.17	0.12	0.00	0.12	3.88	5.05
colon, fetal, donor1	10070-101I7	48.82	8.03	1.85	0.62	0.00	4.33	3.09
common myeloid progenitor CMP, donor1	12130-128D6	45.84	4.58	0.00	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	50.57	9.35	0.85	0.00	0.00	2.97	6.37
cord blood derived cell line:COBL-a 24h infection	10453-106G3	84.07	9.06	0.75	0.30	0.00	3.92	1.81
cord blood derived cell line:COBL-a untreated	10449-106F8	58.38	12.13	0.99	0.14	0.00	3.81	1.97
corpus callosum, adult, pool1	10042-101F6	190.83	11.17	0.77	0.11	0.22	10.72	8.96
cruciate ligament, donor2	10295-104G7	57.54	5.67	0.81	0.81	0.00	4.05	2.43
diaphragm, fetal, donor1	10069-101I6	36.12	11.24	0.80	0.00	0.80	0.80	0.00
diencephalon, adult	10193-103E4	81.12	19.92	0.96	0.48	0.00	3.36	2.88
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	160.96	107.46	2.07	0.23	1.15	3.67	4.36
ductal cell carcinoma cell line:KLM-1	10438-106E6	132.32	8.72	1.54	0.00	0.00	11.54	4.36
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	49.83	11.80	1.69	0.00	0.00	2.89	1.20
ductus deferens, adult	10196-103E7	73.75	6.98	0.50	0.00	0.00	2.49	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	80.65	17.28	1.44	0.00	0.00	4.32	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	43.40	19.86	0.74	0.74	1.47	0.00	3.68
dura mater, adult, donor1	10041-101F5	118.51	5.62	0.50	0.00	0.00	2.89	2.89
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	28.65	4.66	1.78	0.00	0.00	1.11	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	24.36	7.88	1.00	0.00	0.00	0.86	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	62.28	8.02	0.62	0.00	0.00	1.23	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	25.73	8.48	1.21	0.00	0.00	0.91	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	88.92	8.03	0.31	0.00	0.00	5.56	3.09
embryonic pancreas cell line:2C6	10603-108E9	124.78	6.57	0.00	0.00	0.00	2.63	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	50.61	9.39	0.67	0.00	0.34	1.01	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	40.96	22.65	1.81	0.00	0.36	2.17	2.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	34.57	24.28	1.29	0.00	0.00	0.80	0.64
epidermoid carcinoma cell line:A431	10426-106D3	54.02	10.78	0.22	0.00	0.11	1.11	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	53.67	10.01	0.00	0.00	0.00	2.53	2.20
epididymis, adult	10197-103E8	71.79	7.54	1.67	0.00	0.63	2.51	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	55.71	21.47	0.89	0.35	0.71	2.31	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	21.63	8.65	0.79	0.00	0.39	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	115.85	22.41	0.66	0.26	0.39	2.75	3.01
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	99.70	18.21	0.49	0.10	0.20	1.97	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	124.91	20.39	0.90	0.11	0.00	2.24	3.14
esophagus, adult, pool1	10015-101C6	81.01	6.58	0.42	0.00	0.00	4.03	4.46
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	73.26	5.51	0.63	0.00	0.00	2.13	2.38
eye - muscle inferior rectus, donor1	10272-104E2	31.39	12.07	4.83	7.24	0.00	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	35.77	12.63	2.10	0.00	0.00	2.10	2.10
eye - muscle medial, donor2	10299-104H2	19.35	8.93	0.00	0.00	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	36.69	3.44	2.29	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	36.43	11.66	0.00	0.00	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	97.12	24.15	0.76	0.51	0.25	6.61	5.59
fibrosarcoma cell line:HT-1080	10758-110E2	49.75	7.44	0.38	0.00	0.13	1.03	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	44.63	5.22	0.47	0.00	0.00	2.14	2.14
frontal lobe, adult, pool1	10040-101F4	170.57	7.04	0.56	0.09	0.19	6.76	7.60
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	99.38	47.74	4.50	0.60	0.90	3.60	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	22.86	3.84	0.55	0.00	0.00	1.65	1.37
gall bladder, adult	10198-103E9	80.64	7.24	0.24	0.00	0.00	2.66	3.38
gamma delta positive T cells, donor1	11937-126A2	35.97	5.91	0.54	0.00	0.00	1.07	1.61
gamma delta positive T cells, donor2	11938-126A3	28.01	5.98	0.37	0.37	0.00	0.37	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	35.48	39.92	2.75	0.00	0.21	2.96	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	81.23	11.80	0.58	0.00	0.39	1.74	3.48
gastric cancer cell line:AZ521	10549-107H9	113.62	6.89	0.49	0.00	0.00	2.95	3.77
gastric cancer cell line:GSS	10560-108A2	30.20	12.81	0.00	0.00	0.00	0.00	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	97.32	47.29	1.60	0.00	0.23	2.28	1.37
giant cell carcinoma cell line:LU65	10487-107B1	50.83	8.03	0.80	0.00	0.23	4.93	3.56
giant cell carcinoma cell line:Lu99B	10433-106E1	60.88	6.58	0.14	0.00	0.00	2.94	2.24
glassy cell carcinoma cell line:HOKUG	10688-109F4	142.67	15.96	0.75	0.00	0.00	10.23	7.48
glioblastoma cell line:A172, tech_rep1	10444-106F3	57.31	13.30	0.95	0.11	0.11	3.80	2.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	56.88	11.52	1.97	0.14	0.84	2.67	2.81
glioblastoma cell line:T98G	10485-107A8	91.61	19.32	1.21	0.00	0.55	2.65	3.09
glioma cell line:GI-1	10413-106B8	31.92	10.54	0.29	0.00	0.00	1.76	2.93
globus pallidus - adult, donor10196	10175-103C4	135.58	4.37	0.73	0.00	0.00	6.56	3.64
globus pallidus, adult, donor10252	10161-103A8	210.90	19.28	2.69	0.00	1.46	10.98	7.32
globus pallidus, adult, donor10258	10367-105F7	98.58	13.69	5.48	0.00	0.00	8.22	8.22
globus pallidus, newborn, donor10223	10364-105F4	39.97	2.13	0.53	0.00	0.00	2.66	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	14.68	0.00	0.00	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	34.24	16.64	0.96	0.00	0.32	1.60	0.32
hIPS +CCl2, biol_rep1	14383-156B9	129.47	15.61	1.38	0.46	0.92	1.38	0.92
hIPS +CCl2, biol_rep2	14384-156C1	74.08	14.18	1.37	0.00	0.00	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	74.07	14.17	0.64	0.64	0.00	1.29	0.64
hIPS, biol_rep1	14380-156B6	18.68	10.06	0.00	0.00	0.00	1.44	1.44
hIPS, biol_rep2	14381-156B7	56.93	11.66	1.37	0.69	0.69	0.00	2.06
hIPS, biol_rep3	14382-156B8	83.86	8.83	3.31	0.00	1.10	6.62	4.41
hairy cell leukemia cell line:Mo	10712-109I1	78.16	20.11	1.72	0.00	0.00	5.17	2.59
heart - mitral valve, adult	10205-103F7	85.80	11.06	0.30	0.90	0.30	3.59	3.59
heart - pulmonic valve, adult	10206-103F8	80.80	12.03	0.52	0.78	0.52	2.61	5.75
heart - tricuspid valve, adult	10207-103F9	59.12	4.16	0.00	0.83	0.00	0.83	3.33
heart, adult, diseased post-infarction, donor1	10050-101G5	55.71	21.83	1.02	0.00	0.82	3.06	1.63
heart, adult, diseased, donor1	10051-101G6	28.53	10.65	0.43	0.00	0.85	2.98	2.98
heart, adult, pool1	10016-101C7	144.20	1.38	0.46	0.00	0.00	3.91	5.06
heart, fetal, pool1	10046-101G1	116.64	5.44	0.41	0.00	0.21	3.70	3.39
hepatic mesenchymal tumor cell line:LI90	10778-110G4	45.97	6.17	0.31	0.00	0.31	2.47	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	231.89	26.16	0.00	0.00	0.00	5.95	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	106.85	18.56	0.66	0.22	0.11	2.54	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	112.03	20.39	0.24	0.00	0.12	1.70	1.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	104.89	19.91	0.40	0.00	0.00	2.53	1.52
hepatoma cell line:Li-7	10484-107A7	46.04	10.12	0.78	0.00	0.00	0.78	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	70.05	13.77	0.50	0.10	0.20	0.70	1.21
hippocampus - adult, donor10196	10169-103B7	128.70	16.09	1.89	0.00	0.95	11.36	4.73
hippocampus, adult, donor10252	10153-102I9	159.81	23.27	2.65	0.61	1.43	7.55	6.94
hippocampus, adult, donor10258	10374-105G5	50.79	17.93	0.50	1.00	0.00	2.49	3.98
hippocampus, newborn, donor10223	10363-105F3	50.40	5.99	0.70	0.00	0.70	4.93	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	248.41	57.98	2.44	0.61	0.00	6.71	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	97.00	34.36	0.98	0.20	0.20	1.77	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	107.91	28.69	2.03	0.51	0.25	1.27	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	104.88	15.79	2.26	0.00	0.00	7.33	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	140.21	71.52	1.81	0.77	0.52	3.87	2.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	141.97	17.46	2.28	0.38	0.00	3.04	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	62.48	11.97	0.58	0.88	0.00	2.04	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	70.01	16.16	2.37	0.22	0.22	1.08	1.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	49.21	10.84	1.25	0.42	0.00	1.25	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	44.52	13.02	1.66	0.00	0.00	1.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	67.50	21.21	2.89	0.16	0.32	1.29	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	53.19	7.41	1.35	0.00	0.00	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	105.63	33.80	1.41	0.00	0.31	3.76	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	130.19	79.59	1.47	0.49	0.00	2.95	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	102.98	34.04	3.49	0.00	0.00	3.49	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	148.53	22.72	3.05	0.76	0.19	3.44	3.82
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	139.98	17.88	1.74	0.00	0.00	3.49	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	158.92	28.49	4.00	0.00	0.00	7.00	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	82.52	16.01	1.70	0.38	0.00	2.83	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	78.21	12.73	1.36	0.45	0.45	1.82	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	46.05	9.40	1.88	0.00	0.31	1.57	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	65.81	16.33	1.14	0.00	0.00	1.80	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	54.58	12.48	0.87	0.00	0.00	1.74	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	70.25	6.88	2.69	0.00	0.30	2.69	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	117.87	47.11	2.59	0.18	0.37	2.59	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	109.83	27.10	3.14	0.00	0.00	1.71	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	172.31	34.30	2.86	0.00	0.41	3.27	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	133.09	48.59	2.82	0.00	0.00	3.87	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	95.34	20.90	1.58	0.32	0.00	1.58	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	114.69	13.32	3.33	0.00	0.00	2.42	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	57.92	11.38	0.52	0.52	0.00	2.07	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	47.82	7.31	0.66	0.66	0.00	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	44.89	7.44	1.03	0.00	0.26	2.05	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	52.41	17.13	1.79	0.26	0.26	1.28	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	30.29	14.39	0.76	0.00	0.76	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	64.19	8.40	2.35	0.00	0.34	2.35	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	128.96	26.57	2.17	0.24	0.24	1.45	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	153.31	36.10	1.34	0.00	0.00	2.23	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	137.07	22.93	3.90	0.00	0.49	2.93	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	118.58	19.56	0.61	0.61	0.31	2.75	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	845.84	292.79	9.76	0.00	3.25	19.52	26.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	157.53	24.16	3.64	0.33	0.00	5.63	3.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	60.75	10.40	1.09	0.00	0.00	3.28	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	85.04	6.88	0.72	0.00	0.00	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	71.17	9.61	0.71	0.36	0.00	2.14	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	5.97	0.00	0.00	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	85.18	8.94	0.81	0.27	0.14	1.35	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	64.92	7.54	1.89	0.81	0.00	1.35	1.08
immature langerhans cells, donor1	11904-125F5	26.39	3.39	0.48	0.00	0.00	0.48	0.73
immature langerhans cells, donor2	11905-125F6	16.63	3.96	0.00	0.00	0.00	1.58	0.00
insula, adult, pool1	10039-101F3	150.94	7.48	0.38	0.19	0.00	7.57	7.10
keratoacanthoma cell line:HKA-1	10791-110H8	85.51	8.13	0.33	0.00	0.33	3.58	2.60
kidney, adult, pool1	10017-101C8	70.19	6.21	0.30	0.30	0.10	3.10	2.60
kidney, fetal, pool1	10045-101F9	52.77	2.12	0.14	0.00	0.00	1.70	1.70
large cell lung carcinoma cell line:IA-LM	10509-107D5	49.99	1.99	0.43	0.00	0.00	1.14	2.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.71	8.85	0.00	0.14	0.41	1.66	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	123.86	6.97	0.92	0.18	0.18	3.67	3.30
left atrium, adult, donor1	10079-102A7	63.75	14.17	0.54	0.00	1.09	0.54	2.18
left ventricle, adult, donor1	10078-102A6	72.81	7.58	0.51	0.51	1.52	3.03	0.51
leiomyoblastoma cell line:G-402	10721-110A1	77.16	5.47	0.55	0.00	0.27	1.09	1.92
leiomyoma cell line:10964C	10569-108B2	20.48	5.75	0.72	0.00	0.00	3.59	1.80
leiomyoma cell line:15242A	10570-108B3	9.78	7.07	0.54	0.00	0.00	1.09	0.00
leiomyoma cell line:15425	10571-108B4	26.22	14.33	0.73	0.00	0.00	4.86	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	5.23	0.00	0.00	0.00	3.14	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	43.45	5.31	0.47	0.00	0.12	0.71	0.24
liposarcoma cell line:KMLS-1	10782-110G8	31.24	6.09	0.94	0.00	0.00	0.62	0.47
liposarcoma cell line:SW 872	10726-110A6	71.03	7.68	0.73	0.12	0.12	1.22	0.24
liver, adult, pool1	10018-101C9	71.31	8.75	0.81	0.16	0.16	2.27	1.46
liver, fetal, pool1	10086-102B5	32.92	1.88	0.94	1.88	0.00	3.76	1.88
locus coeruleus - adult, donor10196	10182-103D2	116.95	14.58	2.19	1.17	0.44	9.48	7.73
locus coeruleus, adult, donor10252	10165-103B3	141.18	19.75	0.55	0.55	0.74	7.57	7.57
locus coeruleus, adult, donor10258	10375-105G6	62.07	12.98	4.80	0.28	0.56	3.39	3.67
locus coeruleus, newborn, donor10223	10362-105F2	64.78	5.05	0.42	0.00	0.00	7.15	5.89
lung adenocarcinoma cell line:A549	10499-107C4	62.14	2.49	0.00	0.00	0.14	1.11	1.66
lung adenocarcinoma cell line:PC-14	10408-106B3	91.69	6.20	0.00	0.00	0.00	9.65	3.45
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	102.16	7.65	0.40	0.26	0.13	3.69	3.03
lung, adult, pool1	10019-101D1	84.34	2.84	0.35	0.12	0.24	3.19	6.62
lung, fetal, donor1	10068-101I5	81.91	7.71	0.00	0.00	0.00	4.00	5.71
lung, right lower lobe, adult, donor1	10075-102A3	81.10	13.29	1.37	1.37	0.92	1.83	5.50
lymph node, adult, donor1	10077-102A5	82.84	8.99	0.95	0.00	0.00	1.42	2.37
lymphangiectasia cell line:DS-1	10727-110A7	97.31	10.30	0.66	0.22	0.22	1.75	2.85
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	34.71	6.64	0.30	0.00	0.00	1.21	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	58.62	5.10	0.85	0.00	0.00	0.85	0.85
mature adipocyte, donor1	12231-129F8	55.05	1.78	0.89	0.44	0.00	1.78	0.44
mature adipocyte, donor2	12232-129F9	43.17	3.11	0.21	0.00	0.21	2.49	2.91
mature adipocyte, donor3	12233-129G1	39.12	0.71	0.24	0.24	0.00	1.66	0.24
mature adipocyte, donor4	12234-129G2	54.75	5.79	0.26	0.00	0.00	1.84	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	80.77	10.25	0.00	0.00	0.00	8.10	4.77
medial frontal gyrus - adult, donor10196	10170-103B8	165.82	9.02	1.13	0.00	0.00	7.90	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	140.87	22.99	1.66	0.92	0.92	7.36	6.62
medial frontal gyrus, adult, donor10258	10368-105F8	93.72	17.47	2.22	0.64	1.27	5.08	4.45
medial frontal gyrus, newborn, donor10223	10352-105E1	176.57	37.10	0.00	0.00	0.00	10.24	6.40
medial temporal gyrus - adult, donor10196	10183-103D3	119.81	57.54	2.03	0.17	0.68	10.13	6.58
medial temporal gyrus, adult, donor10252	10156-103A3	145.16	17.19	1.70	0.85	3.40	7.22	10.19
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	50.08	13.48	0.00	1.93	5.78	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	818.16	258.37	0.00	0.00	14.35	43.06	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	73.58	6.46	0.00	0.00	0.00	1.79	3.59
medulla oblongata - adult, donor10196	10174-103C3	87.61	8.44	1.30	0.65	0.00	3.89	3.89
medulla oblongata, adult, donor10252	10155-103A2	146.44	17.65	0.62	0.15	0.46	6.19	5.57
medulla oblongata, adult, pool1	10038-101F2	123.91	6.37	0.41	0.08	0.24	6.86	5.14
medulla oblongata, newborn, donor10223	10361-105F1	49.30	5.90	0.00	0.35	0.00	2.43	1.39
medulloblastoma cell line:D283 Med	10838-111E1	211.01	47.60	1.77	0.00	0.00	2.66	3.10
medulloblastoma cell line:ONS-76	10759-110E3	127.90	9.90	0.61	0.00	0.37	1.96	2.81
melanoma cell line:COLO 679	10514-107E1	62.10	6.47	0.43	0.00	0.00	2.30	1.58
melanoma cell line:G-361	10465-106H6	15.47	6.24	0.54	0.00	0.00	1.63	1.90
meningioma cell line:HKBMM	10691-109F7	21.17	5.79	0.18	0.00	0.00	1.27	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	148.92	66.97	7.05	0.00	0.88	0.88	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	65.07	13.48	3.37	0.00	0.00	2.33	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	71.19	16.72	0.00	0.00	0.00	2.30	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	56.17	10.91	0.55	0.00	0.00	0.73	1.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.50	6.63	0.00	0.00	0.00	1.24	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	39.89	6.60	0.56	0.00	0.00	1.26	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.97	8.09	0.19	0.19	0.39	2.12	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	8.33	1.39	0.69	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	30.72	5.66	0.17	0.00	0.17	1.72	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	41.52	7.71	0.23	0.00	0.12	1.61	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	63.40	12.34	0.27	0.00	0.00	1.86	1.59
mesenchymal precursor cell - cardiac, donor4	11755-123G9	62.93	13.37	0.27	0.14	0.00	2.03	2.30
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	59.32	6.26	0.00	0.00	0.00	1.14	2.13
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	21.74	3.29	0.33	0.00	0.00	0.33	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	70.02	9.96	0.28	0.14	0.14	2.08	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.18	14.66	0.70	0.00	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	34.91	14.09	0.20	0.00	0.00	2.04	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.38	7.19	0.36	0.00	0.00	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	37.76	7.24	0.21	0.10	0.00	1.14	1.24
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.26	5.93	0.68	0.00	0.00	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	73.84	21.40	1.26	0.00	0.84	0.84	4.62
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	49.91	8.97	0.30	0.00	0.00	1.20	2.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	48.05	11.29	0.09	0.00	0.00	1.75	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.94	4.42	0.00	0.00	0.00	1.10	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	13.16	8.01	0.57	0.00	0.00	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	30.31	40.84	2.53	0.00	0.42	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	28.31	8.22	0.46	0.00	0.00	0.46	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.35	8.44	0.51	0.00	0.00	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	20.94	7.07	0.00	0.00	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	35.43	9.24	0.92	0.00	0.31	1.23	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.83	8.00	0.47	0.00	0.24	0.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	34.52	7.45	0.34	0.00	0.00	1.35	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	28.69	6.68	0.79	0.00	0.00	1.96	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	34.29	5.56	0.46	0.00	0.00	0.93	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	49.90	7.79	0.87	0.00	0.00	0.58	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	35.70	7.59	0.89	0.00	0.00	1.12	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	34.61	4.09	0.24	0.00	0.24	0.96	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	46.93	5.13	0.00	0.00	0.00	2.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	33.23	7.38	0.67	0.00	0.00	0.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	33.16	6.55	1.64	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	40.38	5.58	0.00	0.00	0.00	1.72	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	15.49	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.28	5.85	0.32	0.00	0.32	1.95	2.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	7.27	0.00	0.00	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.99	6.40	1.07	0.00	0.00	1.60	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	4.91	2.45	0.00	0.00	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	23.71	5.05	0.39	0.00	0.00	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	25.18	2.10	2.10	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	8.94	0.99	0.00	0.99	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	9.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.94	5.34	2.37	0.00	0.00	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	2.44	0.00	0.00	0.00	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	3.80	0.63	0.00	0.00	0.00	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.56	3.45	0.00	0.00	0.00	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	15.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	7.98	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	20.66	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.97	12.22	0.81	0.00	0.00	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.09	11.92	0.79	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.15	9.43	0.00	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.40	6.55	0.00	0.31	0.00	1.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	9.36	0.00	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	15.37	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	48.79	2.57	0.00	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	26.16	18.59	0.69	0.00	0.00	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	48.99	20.29	0.00	0.00	0.00	2.47	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	38.13	25.79	2.24	0.00	0.00	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	36.26	22.26	1.27	0.00	0.64	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	30.22	10.88	0.40	0.00	0.00	0.40	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	13.08	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	15.20	8.87	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.38	6.68	0.61	0.61	0.00	0.00	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	22.59	4.52	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	47.77	16.47	2.47	0.00	0.00	1.65	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.28	3.57	0.79	0.00	0.20	1.19	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	21.74	8.44	0.32	0.00	0.32	0.65	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	17.32	2.04	0.00	0.00	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.21	2.32	0.00	0.00	0.00	0.00	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	99.46	5.43	0.71	0.00	0.00	8.03	5.67
mesothelioma cell line:ACC-MESO-4	10494-107B8	67.65	6.49	0.93	0.00	0.00	2.55	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	25.64	0.00	0.00	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	85.80	25.69	3.08	0.31	0.62	2.16	1.34
mesothelioma cell line:Mero-25	10850-111F4	31.32	17.48	1.13	0.00	0.00	0.68	0.68
mesothelioma cell line:Mero-41	10851-111F5	76.52	27.63	1.47	0.00	0.24	4.89	3.67
mesothelioma cell line:Mero-48a	10852-111F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	68.33	41.00	2.89	0.53	0.53	1.84	1.84
mesothelioma cell line:Mero-83	10854-111F8	92.43	40.34	0.68	0.17	0.51	2.38	1.53
mesothelioma cell line:Mero-84	10855-111F9	26.04	10.36	0.76	0.00	0.00	1.01	0.51
mesothelioma cell line:Mero-95	10856-111G1	72.67	18.01	0.62	0.00	0.41	2.69	2.28
mesothelioma cell line:NCI-H2052	10847-111F1	11.93	16.07	0.50	0.00	0.00	0.83	0.66
mesothelioma cell line:NCI-H226	10846-111E9	60.45	26.42	1.09	0.18	0.18	1.99	2.53
mesothelioma cell line:NCI-H2452	10848-111F2	55.35	12.47	0.68	0.17	0.00	1.54	1.02
mesothelioma cell line:NCI-H28	10845-111E8	67.94	18.58	0.76	0.00	0.25	4.58	3.31
mesothelioma cell line:No36	10857-111G2	98.19	33.60	1.96	0.00	1.63	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	12.46	8.40	0.27	0.00	0.54	1.08	0.81
migratory langerhans cells, donor1	11901-125F2	24.95	2.69	0.00	0.00	0.00	0.77	2.11
migratory langerhans cells, donor2	11902-125F3	15.26	1.10	0.00	0.00	0.00	1.34	1.34
migratory langerhans cells, donor3	11903-125F4	27.46	3.41	0.00	0.00	0.18	0.90	1.79
mixed mullerian tumor cell line:HTMMT	10689-109F5	30.69	60.40	8.49	1.63	0.65	1.63	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	23.31	9.96	1.06	0.00	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	53.21	6.68	0.23	0.23	0.00	1.61	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	43.58	4.38	0.38	0.00	0.00	2.09	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	53.22	12.38	1.66	0.18	0.18	2.40	1.66
myeloma cell line:PCM6	10474-106I6	10.08	6.33	0.20	0.20	0.00	0.79	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	130.88	20.29	2.03	0.00	0.00	2.03	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	45.90	10.59	0.39	0.00	0.39	0.98	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	23.18	2.34	0.22	0.11	0.00	2.34	1.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	24.49	1.99	0.07	0.00	0.00	3.16	2.13
nasal epithelial cells, donor2	12227-129F4	69.55	3.31	0.00	0.00	0.00	1.10	1.66
neuroblastoma cell line:CHP-134	10508-107D4	187.73	9.20	0.69	0.00	0.46	2.99	4.60
neuroblastoma cell line:NB-1	10539-107G8	368.93	24.32	1.68	0.19	0.00	10.66	8.98
neuroblastoma cell line:NBsusSR	10607-108F4	71.28	18.35	0.63	0.00	0.21	2.11	0.84
neuroblastoma cell line:NH-12	10555-107I6	119.82	24.97	1.12	0.00	0.19	2.24	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	178.16	57.65	2.85	0.00	0.95	5.46	4.74
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	124.80	21.06	1.27	0.00	0.16	3.96	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	52.73	28.58	3.02	0.40	0.20	0.81	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	104.90	6.36	0.64	0.64	0.00	1.91	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	31.94	1.06	0.53	0.00	0.00	1.06	1.06
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	79.15	24.52	2.20	0.17	0.00	0.68	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	68.84	14.41	0.00	0.00	0.00	3.20	4.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	26.29	8.98	3.53	0.00	0.96	1.92	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.45	11.04	0.26	0.00	0.00	1.05	1.31
nucleus accumbens, adult, pool1	10037-101F1	151.11	10.97	0.66	0.19	0.09	8.62	6.84
occipital cortex - adult, donor10196	10172-103C1	105.08	10.30	0.00	0.00	0.00	12.36	2.06
occipital cortex, adult, donor10252	10163-103B1	167.73	21.20	2.42	0.81	2.95	7.78	6.98
occipital cortex, newborn, donor10223	10355-105E4	86.25	7.64	0.00	0.00	0.36	5.46	4.37
occipital lobe, adult, donor1	10076-102A4	138.28	4.20	1.84	0.26	1.57	4.72	5.51
occipital lobe, fetal, donor1	10073-102A1	104.27	8.58	1.29	0.86	0.86	3.00	3.43
occipital pole, adult, pool1	10036-101E9	66.07	2.29	0.24	0.08	0.24	3.78	3.63
olfactory region, adult	10195-103E6	155.71	32.48	0.96	0.57	0.96	7.83	6.30
optic nerve, donor1	10277-104E7	90.05	4.00	0.00	0.00	0.00	6.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	32.92	6.15	0.34	0.11	0.00	1.48	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	105.51	7.56	0.41	0.00	0.27	1.79	2.89
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	63.84	40.13	0.68	0.00	0.17	2.03	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	87.21	16.29	0.69	0.00	0.23	1.04	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	25.28	7.06	0.29	0.29	0.00	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	103.71	3.74	0.00	0.00	0.00	0.93	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	113.88	10.82	1.06	0.00	0.00	1.70	1.70
ovary, adult, pool1	10020-101D2	96.17	6.38	0.52	0.17	0.09	3.49	4.28
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	62.33	9.53	1.65	0.00	0.00	1.65	0.92
pancreas, adult, donor1	10049-101G4	38.57	4.70	0.00	0.00	0.00	2.82	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	87.22	9.50	0.56	0.00	0.00	1.96	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	16.01	26.75	1.02	0.00	0.00	0.51	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	54.97	4.31	0.17	0.00	0.17	2.32	2.15
paracentral gyrus, adult, pool1	10035-101E8	144.42	8.88	0.46	0.09	0.09	8.24	6.13
parietal cortex, adult, donor10258	10373-105G4	85.14	9.54	0.00	0.73	0.73	4.40	5.87
parietal lobe - adult, donor10196	10171-103B9	133.55	10.35	0.94	0.00	0.94	11.29	3.76
parietal lobe, adult, donor10252	10157-103A4	133.11	19.38	0.86	0.29	0.57	9.41	7.98
parietal lobe, adult, pool1	10034-101E7	136.50	9.78	0.62	0.35	0.09	8.02	8.28
parietal lobe, fetal, donor1	10072-101I9	46.55	33.94	2.91	1.94	0.97	1.94	1.94
parietal lobe, newborn, donor10223	10356-105E5	93.09	10.47	0.75	0.00	0.37	4.86	3.36
parotid gland, adult	10199-103F1	33.92	6.78	0.62	0.00	0.00	2.47	4.32
penis, adult	10200-103F2	67.14	22.56	2.15	2.15	0.54	1.07	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	46.30	13.95	0.37	0.00	0.00	2.60	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	70.22	17.92	1.02	0.15	0.15	1.46	1.89
pineal gland - adult, donor10196	10179-103C8	119.98	6.45	1.94	0.00	1.29	6.45	6.45
pineal gland, adult, donor10252	10160-103A7	156.34	7.11	1.18	0.59	0.00	5.92	10.07
pineal gland, adult, donor10258	10377-105G8	94.06	11.29	1.25	0.00	1.25	11.29	5.02
pituitary gland - adult, donor10196	10180-103C9	115.35	11.13	1.01	0.00	0.00	9.11	11.13
pituitary gland, adult, donor10252	10162-103A9	131.34	12.51	1.04	0.00	0.00	8.34	2.61
pituitary gland, adult, donor10258	10378-105G9	83.42	15.32	0.85	0.00	0.00	1.70	1.70
placenta, adult, pool1	10021-101D3	51.49	2.58	0.11	0.00	0.00	3.55	2.90
plasma cell leukemia cell line:ARH-77	10840-111E3	67.67	10.06	0.26	0.00	0.00	2.38	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	38.75	5.76	0.78	0.16	0.00	1.40	1.40
pons, adult, pool1	10033-101E6	115.33	11.71	0.60	0.00	0.34	6.28	4.56
postcentral gyrus, adult, pool1	10032-101E5	97.55	6.71	0.52	0.00	0.09	4.45	5.23
promyelocytes/myelocytes PMC, donor1	12132-128D8	27.19	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	115.95	21.12	1.89	0.00	0.29	4.95	3.35
prostate cancer cell line:PC-3	10439-106E7	106.36	26.32	0.91	0.18	0.36	3.09	2.90
prostate, adult, pool1	10022-101D4	67.11	4.53	0.45	0.18	0.27	2.81	3.90
putamen, adult, donor10196	10176-103C5	238.66	31.40	0.47	0.00	0.47	12.28	14.64
putamen, adult, donor10252	10152-102I8	72.55	11.76	9.80	0.00	3.92	7.84	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	54.64	7.65	1.09	0.00	0.00	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	119.60	29.24	1.21	0.24	0.97	10.87	7.25
putamen, newborn, donor10223	10365-105F5	83.21	7.50	0.00	0.00	0.00	3.75	4.50
rectal cancer cell line:TT1TKB	10469-106I1	102.99	6.98	0.29	0.00	0.00	2.04	3.20
rectum, fetal, donor1	10067-101I4	100.15	5.56	0.00	0.00	0.00	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	16.54	7.84	0.42	0.00	0.21	0.21	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	13.25	15.74	2.90	0.00	0.00	0.41	0.41
retina, adult, pool1	10030-101E3	101.49	7.16	0.40	0.00	0.00	3.18	5.07
retinoblastoma cell line:Y79	10475-106I7	59.75	31.18	2.34	0.26	0.52	1.82	2.34
rhabdomyosarcoma cell line:KYM-1	10787-110H4	92.09	10.82	1.72	0.25	0.25	1.11	1.35
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	179.12	16.59	2.25	0.28	0.00	4.22	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	50.78	6.06	0.00	0.00	0.76	0.76	2.27
salivary acinar cells, donor1	11771-123I7	46.61	6.47	0.32	0.00	0.16	1.29	1.62
salivary acinar cells, donor2	11772-123I8	63.34	17.90	0.28	0.00	0.00	1.65	2.20
salivary acinar cells, donor3	11773-123I9	85.40	7.94	0.66	0.00	0.00	3.31	3.31
salivary gland, adult, pool1	10093-102C3	25.74	7.44	0.57	0.00	0.57	2.29	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	35.92	5.65	0.67	0.00	0.00	2.95	2.36
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	41.97	6.35	0.47	0.00	0.00	1.18	2.70
seminal vesicle, adult	10201-103F3	81.48	12.70	4.23	0.53	1.06	6.35	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	22.83	7.53	0.24	0.00	0.00	1.46	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.33	3.52	0.50	0.50	0.00	0.75	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	37.13	17.06	0.00	0.00	0.00	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	65.68	15.58	0.67	0.00	0.00	2.82	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	16.80	5.08	0.11	0.00	0.00	0.66	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	49.16	4.64	0.26	0.00	0.00	2.97	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	26.95	27.66	0.71	0.71	0.71	2.84	3.55
skeletal muscle, adult, pool1	10023-101D5	92.71	3.00	0.36	0.12	0.12	4.68	4.92
skeletal muscle, fetal, donor1	10066-101I3	34.17	5.03	0.00	1.01	0.00	4.02	0.00
skin, adult, donor1	10074-102A2	67.85	6.79	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	51.76	4.42	1.26	0.63	1.26	1.26	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	60.03	7.34	0.67	0.00	0.00	1.00	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	151.30	63.67	2.52	0.00	0.32	3.78	5.04
small cell lung carcinoma cell line:DMS 144	10841-111E4	47.80	13.49	1.16	0.00	0.19	1.73	1.54
small cell lung carcinoma cell line:LK-2	10541-107H1	187.74	8.90	0.33	0.33	0.00	6.92	4.12
small cell lung carcinoma cell line:NCI-H82	10842-111E5	174.52	30.08	0.80	0.00	0.32	7.72	6.43
small cell lung carcinoma cell line:WA-hT	10562-108A4	112.66	17.22	0.44	0.00	0.00	1.31	1.09
small intestine, adult, pool1	10024-101D6	48.49	3.82	0.00	0.00	0.00	2.87	3.22
small intestine, fetal, donor1	10064-101I1	66.34	23.59	0.49	0.00	0.49	2.70	3.44
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.90	12.31	1.54	0.00	0.00	1.03	3.59
smooth muscle, adult, pool1	10048-101G3	125.61	16.54	0.52	0.52	0.00	4.14	6.72
somatostatinoma cell line:QGP-1	10781-110G7	88.18	2.95	0.00	0.00	0.00	3.75	4.02
spinal cord - adult, donor10196	10181-103D1	126.17	31.89	1.15	0.69	1.38	8.72	6.42
spinal cord, adult, donor10252	10159-103A6	164.41	10.25	1.18	0.00	0.79	6.31	5.91
spinal cord, adult, donor10258	10369-105F9	103.77	22.14	0.00	0.00	0.00	4.84	2.77
spinal cord, fetal, donor1	10056-101H2	132.94	11.59	2.44	0.00	1.83	3.66	4.88
spinal cord, newborn, donor10223	10359-105E8	88.63	11.94	0.46	0.00	0.46	5.51	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	51.68	4.63	0.30	0.15	0.15	1.34	1.94
spleen, adult, pool1	10025-101D7	57.27	4.07	0.44	0.11	0.00	2.31	2.86
spleen, fetal, pool1	10044-101F8	45.69	1.19	0.16	0.08	0.00	1.83	2.30
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	58.17	8.80	0.10	0.00	0.00	2.59	2.28
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	71.77	10.82	1.14	0.19	0.00	2.66	1.71
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	78.28	47.53	1.75	0.70	0.00	2.80	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	21.50	4.69	0.00	0.00	0.00	2.35	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	20.26	6.08	1.01	0.00	0.00	1.46	1.69
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	30.92	17.37	0.42	0.00	0.00	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.31	4.65	0.85	0.42	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	124.95	5.34	0.00	0.00	0.00	1.07	3.20
submaxillary gland, adult	10202-103F4	41.02	10.82	0.00	0.00	0.00	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	976.93	0.00	0.00	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	184.65	24.92	1.25	0.21	0.62	8.52	6.85
substantia nigra, adult, donor10258	10371-105G2	69.83	8.79	1.55	0.00	0.00	6.21	1.55
substantia nigra, newborn, donor10223	10358-105E7	39.57	2.83	0.00	0.00	0.00	1.41	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	77.95	35.31	4.13	0.23	0.23	1.38	1.60
temporal lobe, adult, pool1	10031-101E4	82.40	6.10	0.51	0.08	0.08	3.98	3.73
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	89.03	10.68	2.14	0.00	0.00	3.56	4.99
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	52.31	5.71	1.76	0.00	0.44	1.32	4.40
tenocyte, donor1	11763-123H8	55.51	35.26	2.79	0.35	0.00	3.84	1.40
tenocyte, donor2	11765-123I1	38.91	18.31	1.14	0.00	0.00	2.67	1.14
tenocyte, donor3	11768-123I4	57.45	28.17	1.11	0.00	0.74	1.48	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	145.32	29.74	1.36	0.68	0.17	3.91	2.72
teratocarcinoma cell line:NCR-G1	10798-110I6	193.92	33.14	2.62	0.15	0.46	1.08	0.77
teratocarcinoma cell line:PA-1	10807-111A6	97.17	29.45	1.24	0.00	0.15	0.93	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	120.35	15.74	0.89	0.25	0.38	2.03	2.16
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	130.85	20.80	0.76	0.00	0.38	2.27	3.78
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	162.83	22.47	0.22	0.11	0.00	3.05	2.73
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	157.97	89.57	0.98	0.33	0.65	2.61	3.26
testis, adult, pool1	10026-101D8	85.47	5.48	1.18	0.00	0.11	5.15	2.68
testis, adult, pool2	10096-102C6	43.30	15.34	0.00	0.00	0.00	3.61	3.61
thalamus - adult, donor10196	10168-103B6	140.21	16.56	3.31	0.00	2.21	9.94	9.94
thalamus, adult, donor10252	10154-103A1	176.29	21.72	0.63	0.00	0.94	8.60	7.35
thalamus, adult, donor10258, tech_rep1	10370-105G1	53.89	4.62	3.08	3.08	3.08	7.70	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	53.19	14.00	4.45	1.65	1.65	5.11	3.13
thalamus, newborn, donor10223	10366-105F6	37.97	7.48	1.15	0.00	1.15	2.88	1.73
throat, adult	10209-103G2	83.39	4.24	1.00	0.50	0.00	3.75	4.99
throat, fetal, donor1	10061-101H7	92.63	13.41	2.74	0.61	0.91	2.13	2.13
thymic carcinoma cell line:Ty-82	10803-111A2	22.46	8.55	0.99	0.20	0.20	0.60	0.99
thymus, adult, pool1	10027-101D9	141.57	8.25	0.30	0.00	0.20	3.98	3.08
thymus, fetal, pool1	10043-101F7	101.00	5.51	0.21	0.00	0.00	2.91	2.08
thyroid carcinoma cell line:KHM-5M	10776-110G2	57.17	6.52	0.66	0.13	0.27	1.99	1.99
thyroid carcinoma cell line:TCO-1	10783-110G9	92.61	14.81	0.98	0.14	0.56	1.96	1.26
thyroid, adult, pool1	10028-101E1	110.95	5.88	0.75	0.00	0.00	3.92	4.48
thyroid, fetal, donor1	10060-101H6	101.51	22.15	3.43	0.26	0.26	3.95	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	43.11	6.16	0.00	0.00	0.00	3.08	3.08
tongue, adult	10203-103F5	53.73	14.88	0.00	0.00	0.00	4.19	3.26
tongue, fetal, donor1	10059-101H5	109.56	17.73	1.18	0.39	0.00	3.94	6.70
tonsil, adult, pool1	10047-101G2	76.33	2.60	0.30	0.10	0.10	2.60	2.20
trachea, adult, pool1	10029-101E2	47.36	3.19	0.16	0.08	0.00	2.13	1.88
trachea, fetal, donor1	10058-101H4	89.63	13.08	0.77	0.38	0.38	3.46	4.62
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	51.37	15.23	0.71	0.35	0.00	1.77	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	33.94	6.99	0.41	0.00	0.10	0.61	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	97.62	11.12	1.88	0.00	0.00	3.45	1.57
tridermal teratoma cell line:HGRT	10694-109G1	167.42	3.81	0.00	0.00	0.00	3.81	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	29.37	3.39	0.17	0.00	0.00	0.85	0.93
umbilical cord, fetal, donor1	10057-101H3	60.51	8.35	2.09	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	80.71	6.14	0.17	0.17	0.17	4.95	5.63
uterus, fetal, donor1	10055-101H1	136.17	14.33	2.05	0.00	0.00	2.05	6.14
vagina, adult	10204-103F6	43.30	1.94	0.65	0.00	0.00	0.65	1.29
vein, adult	10191-103E2	44.28	5.70	0.88	0.00	0.00	0.44	2.85
xeroderma pigentosum b cell line:XPL 17	10563-108A5	41.12	6.14	0.27	0.00	0.27	1.34	1.34